LOVELACE BIOMEDICAL RESEARCH INSTITUTE

Reduce your risk when donating: see where the money actually goes.

Cite this

Plain text LOVELACE BIOMEDICAL RESEARCH INSTITUTE. furp.org, nonprofit organization profile, tax years 2009–2024. https://furp.org/org/lovelace-biomedical-research-institute-850110669. Retrieved 2026-11-03.

APA furp.org. (n.d.). LOVELACE BIOMEDICAL RESEARCH INSTITUTE [Nonprofit organization profile; tax years 2009–2024]. Retrieved November 3, 2026, from https://furp.org/org/lovelace-biomedical-research-institute-850110669

MLA “LOVELACE BIOMEDICAL RESEARCH INSTITUTE.” furp.org, tax years 2009–2024, https://furp.org/org/lovelace-biomedical-research-institute-850110669. Accessed 3 Nov. 2026.

Retrieved 2026-11-03; covers tax years 2009–2024. Data: furp.org, CC BY 4.0.

2024 · Form 990 · revenue $83.4M · expenses $87.7M · assets $255.5M

EIN: 85-0110669
Address: 2425 RIDGECREST DR SE, ALBUQUERQUE, NM 87108-5129
Website: WWW.LOVELACEBIOMEDICAL.ORG
NTEE code: H920
Exempt type: 501(c)(3): charitable, religious, educational, scientific or literary (corporation)
Ruling date: October 1969 (when the IRS recognized its exemption)
IRS status: Exempt (unconditional) (IRS Business Master File) IRS data ↗
Tax-deductible donations: Yes: listed in IRS Publication 78 (public charity) Pub 78 ↗
Foundation status: Public charity supported by the public (170(b)(1)(a)(vi))
Cross-check: ProPublica Nonprofit Explorer

Mission

THE LOVELACE BIOMEDICAL RESEARCH INSTITUTE (LBRI) IS A PRIVATE, BIOMEDICAL RESEARCH ORGANIZATION DEDICATED TO IMPROVING PUBLIC HEALTH THROUGH RESEARCH ON THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF DISEASES. LBRI IS DEDICATED TO THE DISCOVERY AND ADVANCEMENT OF CLINICAL SOLUTIONS FOR PREVENTION, DIAGNOSIS, TREATMENT AND CURING DISEASES THROUGH RESEARCH. THE RESEARCH IS AIMED AT UNDERSTANDING THEIR CAUSES AND BIOLOGICAL MECHANISMS; ASSESSING AND ELIMINATING EXPOSURES TO RESPIRATORY, NEUROLOGICAL AND OTHER HEALTH HAZARDS; MENTAL ILLNESS; TRAUMATIC BRAIN INJURY AND OTHER BRAIN DISORDERS; AND DEVELOPING IMPROVED THERAPEUTICS, VACCINES, AND DIAGNOSTICS. LBRI IS BASED IN ALBUQUERQUE, NEW MEXICO.

Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).

People paid by the organization

48 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.

Name	Latest title	Years	Latest year pay	Total pay from here	Organizations
Robert W Rubin Phd	CEO (THROUGH 5/31/25)	2009-2024	$845,514	$10,355,678	3
Shannon L Toma	EXEC VP, COO, CFO	2012-2024	$770,069	$3,583,894	3
Dr Alan Kadish	PRESIDENT AND CHAIRMAN OF THE BOARD	2023-2024	$1,387,128	$2,556,338	13
David M Flanders	VP, HUMAN RESOURCES	2016-2024	$323,781	$2,281,218	1
Kent Kiehl	EXECUTIVE SCIENCE OFFICER	2020-2024	$375,938	$1,998,796	2
Steven A Belinsky	VP, ACADEMIC RESEARCH/SR SCIENTIST	2023-2024	$435,984	$887,175	2
Nicholas S Janiga	SPECIAL APPOINTEE	2022-2024	$426,623	$851,382	1
Matthew F Bonilla	SPECIAL APPOINTEE	2022-2024	$380,864	$725,993	1
Salomon Amar	CEO (STARTING 6/1/25)	2024	$712,816	$712,816	6
Melanie Doyle-Eisele	SR. DIRECTOR OF LIFE SCIENCES	2020-2024	$334,422	$574,347	2
Phillip Kuehl	SR. DIR., PRECLINICAL DRUG DEVELOPMENT	2024	$328,637	$328,637	1
Charles Mattiello	SPECIAL APPOINTEE	2024	$258,618	$258,618	1
Wanda Hernandez	SPECIAL APPOINTEE (THRU 9/23/24)	2022-2024	$0	$226,858	1
Jacob D Mcdonald (former)	VP APPLIED SCIENCE (THRU 9/7/2023)	2020-2023	$328,817	$1,547,623	2
Shannon Toma Treasurer (former)	EXEC VP, COO/CFO	2020-2021	$786,660	$1,482,548	1
Steven Belinsky Vp Academic (former)	RESEARCH / SR. SCIENTIST	2020-2022	$438,795	$1,333,949	1
Alan Kadish President (former)	AND CHAIRMAN OF THE BOARD	2022	$1,309,613	$1,309,613	1
Andrew R Mayer (former)	VP OF INTERDISCIPLINARY SCIENCE	2020-2023	$324,295	$1,208,389	2
Edward G Barrett (former)	SR. DIRECTOR OF PHARMACOLOGY	2020-2023	$313,220	$1,145,355	2
Cheryl Devaul (former)	CHIEF HUMAN RESOURCES OFFICER	2009-2012	$236,763	$880,161	2
Richard Mcgivney (former)	CHIEF FINANCIAL OFFICER	2009-2011	$254,102	$736,542	1
Patricia Marx (former)	VICE PRESIDENT	2009-2010	$364,743	$710,358	2
Frances Fulps-Laur (former)	ASSISTANT SECRETARY (THRU 2/28/22)	2009-2021	$126,920	$678,861	2
Matthew Reed (former)	Dir PreClin Drug Dev/Scientist	2011-2016	$225,330	$655,057	1
Chester Leach (former)	SCIENTIST EMERITUS	2016-2019	$210,520	$598,172	1
Nancy L Crowley (former)	SENIOR PROGRAMMER/ANALYST	2009-2012	$130,268	$521,111	1
Gary Larue (former)	CORPORATE CONTROLLER	2009-2011	$170,328	$483,251	1
William Bechtold (former)	DIRECTOR TECHNOLOGY TRANSFER	2009-2011	$168,851	$479,783	1
Christopher Merriam-Leith (former)	DIRECTOR OF BUSINESS AFFAIRS	2011-2012	$184,386	$361,157	1
Loretta Guerra (former)	DIRECTOR HUMAN RESOURCES	2011-2012	$178,590	$352,951	1
Scott Thatcher (former)	VP, FINANCE (THROUGH JAN 2021)	2020	$331,299	$331,299	1
Rachel M Blea (former)	DIRECTOR OF ITS	2011-2012	$165,860	$306,391	1
Richard Mcgivney Through Mid-2013 (former)	CHIEF FINANCIAL OFFICER	2012	$262,647	$262,647	1
Michael K Silber (former)	PROGRAM MANAGER, ERP	2010-2012	$131,211	$258,272	1
Matthew Reed Through 0318 (former)	DIR PRECILIN DRUG DEV/SCIENTIST	2017	$242,640	$242,640	1
Erica Smith (former)	SR. DIR. COM SALES & MARK	2017	$210,301	$210,301	1
Margaret Dunbar Throug - 08252017 (former)	Gnrl Cnsl & SR Dir of Bus Affa- Former	2016	$206,637	$206,637	1
Chester Leach Jr (former)	SCIENTIST EMERITUS	2011	$187,051	$187,051	1
Gary Larue Through December 2013 (former)	CORPORATE CONTROLLER	2012	$179,320	$179,320	1
David Byrd through- 041917 (former)	CFO	2016	$175,647	$175,647	1
Nandakumar Ranganathan (former)	DIRECTOR OF IT	2019	$164,237	$164,237	1
Lucille Maestas Former - 012717 (former)	Assoc Director of ORC and PMO - Former	2016	$157,891	$157,891	1
Julie Nickerson Former - 121916 (former)	Controller - Former	2016	$157,101	$157,101	1
Margaret Dunbar Through - 0817 (former)	GNRL CNSL & SR DIR OF BUS	2017	$154,664	$154,664	1
Margaret Mcmullen (former)	BUS DEV OPS MANAGER	2019	$147,652	$147,652	1
Buffie Kerstetter (former)	BUSINESS DEVELOP MANAGER	2019	$140,501	$140,501	1
Joe Mauderly (former)	VICE PRESIDENT	2010	$136,082	$136,082	2
Frances Felps-Laur (former)	RECORDING/ASSISTANT SECRETARY	2011	$111,321	$111,321	1

Officers and directors, no compensation reported

54 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.

Name	Latest title	Years	Hrs/wk (latest)	Compensation	Organizations
Jane Delgado	DIRECTOR	2009-2024	2	$0 reported	1
Jackie Lovelace Johnson	DIRECTOR	2009-2024	2	$0 reported	3
Jospeh D Mark	DIRECTOR	2023-2024	2	$0 reported	1
Lawrence D Platt	DIRECTOR	2022-2024	2	$0 reported	1
Margaret Retter	DIRECTOR	2022-2024	2	$0 reported	5
Zvigmond Ryzman	DIRECTOR	2022-2024	2	$0 reported	1
Chris Spencer Cpa Dir (former)	CHAIR BUDGET & FINANCE(THRU 7/5/22)	2022	2	$0 reported	1
Pamela Sullivan Dir Chair (former)	AUDIT & COMPENSATION (THRU 7/5/22)	2019-2022	2	$0 reported	1
J Grant Burcham (former)	DIRECTOR (THRU 7/5/22)	2016-2022	2	$0 reported	1
Tess Burleson (former)	DIRECTOR (THRU 7/5/22)	2016-2022	2	$0 reported	2
Sandra Chavez (former)	DIRECTOR (THRU 7/5/22)	2016-2022	2	$0 reported	1
Major General John Doesburg (former)	DIRECTOR (THRU 7/5/22)	2010-2022	2	$0 reported	1
Gregory Downey Md (former)	DIRECTOR (THRU 7/5/22)	2011-2022	2	$0 reported	1
Terry Dunlay (former)	DIRECTOR (THRU 7/5/22)	2016-2022	2	$0 reported	1
Sara Easterson-Bond (former)	DIRECTOR (THRU 7/5/22)	2016-2022	2	$0 reported	2
Joseph D Mark (former)	DIRECTOR	2022	2	$0 reported	1
Melvin Twiest Md (former)	DIRECTOR (THRU 7/5/22)	2009-2022	2	$0 reported	1
Richard Gill Phd (former)	DIRECTOR (THRU 7/5/22)	2016-2022	2	$0 reported	1
Jane Delgado Dir Vice Chair (former)	OF NOMINATING COMMITTEE	2019-2021	2	$0 reported	1
Chris Spencer Cpa Dir Chair (former)	BUDGET & FINANCE COMMITTEE	2019-2021	2	$0 reported	1
Augustine Choi Md (former)	DIRECTOR (THROUGH DECEMBER 2019)	2011-2019	2	$0 reported	1
Chris Spencer Cpa (former)	DIR, CHAIR - BUDGET & FINA	2016-2017	2	$0 reported	2
James Swenberg Dvmphd Thru 048 (former)	DIR, CHAIR - RESEARCH PROGRAMS	2017	2	$0 reported	1
Pamela Sullivan (former)	DIR, CHAIR - AUDIT & COMPE	2011-2017	2	$0 reported	1
David Durgin Through 0418 (former)	DIR, CHAIR - ALTERNATIVE	2017	2	$0 reported	1
Jack Mccarthy Md (former)	DIRECTOR	2009-2017	2	$0 reported	1
Joe Fulcher Through 1017 (former)	DIRECTOR	2017	2	$0 reported	1
James Swenberg DVM PHD (former)	Dir, Chair - Research Program Oversight	2009-2016	2	$0 reported	1
David Durgin (former)	Dir, Chair - Alternative Investment Committee	2009-2016	2	$0 reported	1
Joe Fulcher (former)	Director	2009-2016	2	$0 reported	1
Judy Jones (former)	SECRETARY	2009-2012	2	$0 reported	2
Jacqueline Lovelace Johnson (former)	CHAIR, BOARD OF DIRECTORS	2011-2012	2	$0 reported	2
Frank Bond (former)	VICE CHAIR & CHAIR NOMINATING COMMITTEE	2009-2012	2	$0 reported	1
Catherine Sellman (former)	DIRECTOR	2011-2012	2	$0 reported	1
Christopher Spencer Cpa (former)	DIRECTOR	2011-2012	2	$0 reported	1
John Shelton (former)	DIRECTOR	2009-2012	2	$0 reported	1
Norman Corzine (former)	DIRECTOR	2011-2012	2	$0 reported	2
Sara Easterson-Bond Mfa (former)	DIRECTOR	2011-2012	2	$0 reported	1
W Phelps Anderson (former)	DIRECTOR	2010-2012	2	$0 reported	1
Norm Corzine (former)	BOARD OF DIRECTORS	2009-2010	2	$0 reported	2
Patricia Buffler (former)	VICE CHAIR AND CHAIR RESEARCH PROGRAM OVERSIGHT CO	2009-2010	2	$0 reported	1
Sonia Buist (former)	BOARD OF DIRECTORS	2010	2	$0 reported	1
Martin Hickey Md (former)	BOARD OF DIRECTORS	2009-2010	2	$0 reported	1
Pope Mosely Md Ms (former)	BOARD OF DIRECTORS	2010	2	$0 reported	1
Barbara Rogers (former)	BOARD OF DIRECTORS	2009-2010	2	$0 reported	1
Ernest Romero (former)	BOARD OF DIRECTORS	2010	2	$0 reported	1
Donald E Kilgore Jr Md (former)	BOARD OF DIRECTORS	2010	2	$0 reported	1
Lisa Guillermin Gable (former)	BOARD OF DIRECTORS	2009-2010	2	$0 reported	1
Pam Sullivan (former)	BOARD OF DIRECTORS	2009-2010	2	$0 reported	1
Phelps Anderson (former)	DirECTOR	2009	2	$0 reported	1
John Doesburg (former)	DIRECTOR	2009	2	$0 reported	1
Don Kilgore Jr MD (former)	DIRECTOR	2009	2	$0 reported	1
Pope Moseley MD (former)	DIRECTOR	2009	2	$0 reported	1
Ernie Romero (former)	DIRECTOR	2009	2	$0 reported	1

People by year

2024 · 19 people listed · 12 paid, $6.6M · 495 employees · 6 volunteers

Name	Title	Hrs/wk	From org	From related	Other	Total	Orgs
ALAN KADISH	PRESIDENT AND CHAIRMAN OF THE BOARD	2	$0	$1,265,315	$121,813	$1,387,128	13
ROBERT W RUBIN PHD	CEO (THROUGH 5/31/25)	38	$782,222	$0	$63,292	$845,514	3
SHANNON L TOMA	EXEC VP, COO, CFO	40	$705,999	$0	$64,070	$770,069	3
SALOMON AMAR	CEO (STARTING 6/1/25)	38	$0	$641,578	$71,238	$712,816	6
STEVEN A BELINSKY	VP, ACADEMIC RESEARCH/SR SCIENTIST	40	$395,524	$0	$40,460	$435,984	2
NICHOLAS S JANIGA	SPECIAL APPOINTEE	2	$0	$355,397	$71,226	$426,623	1
MATTHEW F BONILLA	SPECIAL APPOINTEE	2	$0	$333,033	$47,831	$380,864	1
KENT KIEHL	EXECUTIVE SCIENCE OFFICER	40	$334,368	$0	$41,570	$375,938	2
MELANIE DOYLE-EISELE	SR. DIRECTOR OF LIFE SCIENCES	40	$295,478	$0	$38,944	$334,422	2
PHILLIP KUEHL	SR. DIR., PRECLINICAL DRUG DEVELOPMENT	40	$296,621	$0	$32,016	$328,637	1
DAVID M FLANDERS	VP, HUMAN RESOURCES	40	$289,027	$0	$34,754	$323,781	1
CHARLES MATTIELLO	SPECIAL APPOINTEE	2	$0	$233,171	$25,447	$258,618	1
JANE DELGADO	DIRECTOR	2	$0	$0	$0	$0	1
WANDA HERNANDEZ	SPECIAL APPOINTEE (THRU 9/23/24)	2	$0	$0	$0	$0	1
JACKIE LOVELACE JOHNSON	DIRECTOR	2	$0	$0	$0	$0	3
JOSPEH D MARK	DIRECTOR	2	$0	$0	$0	$0	1
LAWRENCE D PLATT	DIRECTOR	2	$0	$0	$0	$0	1
MARGARET RETTER	DIRECTOR	2	$0	$0	$0	$0	5
ZVIGMOND RYZMAN	DIRECTOR	2	$0	$0	$0	$0	1

2023 · 18 people listed · 12 paid, $6.1M · 531 employees · 10 volunteers

Name	Title	Hrs/wk	From org	From related	Other	Total	Orgs
ALAN KADISH	PRESIDENT AND CHAIRMAN OF THE BOARD	2	$0	$1,049,960	$119,250	$1,169,210	13
ROBERT W RUBIN PHD	CEO, ADVISORY NON-VOTING DIRECTOR	38	$874,428	$0	$67,507	$941,935	3
SHANNON L TOMA	TREASURER, EXEC VP, COO, CFO	40	$713,675	$0	$47,523	$761,198	3
STEVEN A BELINSKY	VP ACADEMIC RESEARCH/SR SCIENTIST	40	$404,462	$0	$46,729	$451,191	2
KENT KIEHL	EXECUTIVE SCIENCE OFFICER	40	$386,988	$0	$43,066	$430,054	2
NICHOLAS S JANIGA	SPECIAL APPOINTEE	2	$0	$345,982	$78,777	$424,759	1
DAVID M FLANDERS	VP, HUMAN RESOURCES	40	$314,924	$0	$38,681	$353,605	1
MATTHEW F BONILLA	SPECIAL APPOINTEE	2	$0	$300,777	$44,352	$345,129	1
JACOB D MCDONALD	VP APPLIED SCIENCE (THRU 9/7/2023)	40	$287,941	$0	$40,876	$328,817	2
ANDREW R MAYER	VP OF INTERDISCIPLINARY SCIENCE	40	$282,904	$0	$41,391	$324,295	2
EDWARD G BARRETT	SR. DIRECTOR OF PHARMACOLOGY	40	$268,562	$0	$44,658	$313,220	2
WANDA HERNANDEZ	SPECIAL APPOINTEE	2	$0	$195,253	$31,605	$226,858	1
JANE DELGADO	DIR. VICE CHAIR NOM COMMITTEE	2	$0	$0	$0	$0	1
JACKIE LOVELACE JOHNSON	CHAIRWOMAN OF THE BOARD, DIRECTORS	2	$0	$0	$0	$0	3
JOSPEH D MARK	DIRECTOR	2	$0	$0	$0	$0	1
LAWRENCE D PLATT	DIRECTOR	2	$0	$0	$0	$0	1
MARGARET RETTER	DIRECTOR	2	$0	$0	$0	$0	5
ZVIGMOND RYZMAN	DIRECTOR	2	$0	$0	$0	$0	1

2022 · 29 people listed · 9 paid, $5.1M · 503 employees · 9 volunteers

Name	Title	Hrs/wk	From org	From related	Other	Total	Orgs
ALAN KADISH PRESIDENT	AND CHAIRMAN OF THE BOARD	2	$37,907	$1,044,121	$227,585	$1,309,613	1
ROBERT RUBIN PHD	CEO, ADVISORY NON-VOTING DIRECTOR	39	$850,098	$0	$104,504	$954,602	3
SHANNON TOMA	EXEC VP, COO/CFO	39	$666,454	$0	$40,295	$706,749	3
STEVEN BELINSKY VP ACADEMIC	RESEARCH / SR. SCIENTIST	40	$397,874	$0	$40,921	$438,795	1
JACOB MCDONALD	VP, APPLIED SCIENCE	40	$355,090	$0	$43,582	$398,672	2
KENT KIEHL	EXECUTIVE SCIENCE OFFICER	40	$357,680	$0	$40,416	$398,096	2
DAVID FLANDERS	VP, HUMAN RESOURCES	40	$286,667	$0	$34,159	$320,826	1
ANDREW MAYER	VP, INTERDISCIPLINARY SCIE	40	$250,931	$0	$39,232	$290,163	2
EDWARD BARRETT	SR. DIRECTOR, PHARMACOLOGY	40	$247,479	$0	$38,800	$286,279	2
JACKIE LOVELACE JOHNSON	DIRECTOR	2	$0	$0	$0	$0	3
JANE DELGADO	DIRECTOR	2	$0	$0	$0	$0	1
CHRIS SPENCER CPA DIR	CHAIR BUDGET & FINANCE(THRU 7/5/22)	2	$0	$0	$0	$0	1
PAMELA SULLIVAN DIR CHAIR	AUDIT & COMPENSATION (THRU 7/5/22)	2	$0	$0	$0	$0	1
MATTHEW F BONILLA	SPECIAL APPOINTEE	2	$0	$0	$0	$0	1
J GRANT BURCHAM	DIRECTOR (THRU 7/5/22)	2	$0	$0	$0	$0	1
TESS BURLESON	DIRECTOR (THRU 7/5/22)	2	$0	$0	$0	$0	2
SANDRA CHAVEZ	DIRECTOR (THRU 7/5/22)	2	$0	$0	$0	$0	1
MAJOR GENERAL JOHN DOESBURG	DIRECTOR (THRU 7/5/22)	2	$0	$0	$0	$0	1
GREGORY DOWNEY MD	DIRECTOR (THRU 7/5/22)	2	$0	$0	$0	$0	1
TERRY DUNLAY	DIRECTOR (THRU 7/5/22)	2	$0	$0	$0	$0	1
SARA EASTERSON-BOND	DIRECTOR (THRU 7/5/22)	2	$0	$0	$0	$0	2
WANDA HERNANDEZ	SPECIAL APPOINTEE	2	$0	$0	$0	$0	1
JOSEPH D MARK	DIRECTOR	2	$0	$0	$0	$0	1
NICHOLAS S JANIGA	SPECIAL APPOINTEE	2	$0	$0	$0	$0	1
LAWRENCE D PLATT	DIRECTOR	2	$0	$0	$0	$0	1
MARGARET RETTER	DIRECTOR	2	$0	$0	$0	$0	5
ZVIGMOND RYZMAN	DIRECTOR	2	$0	$0	$0	$0	1
MELVIN TWIEST MD	DIRECTOR (THRU 7/5/22)	2	$0	$0	$0	$0	1
RICHARD GILL PHD	DIRECTOR (THRU 7/5/22)	2	$0	$0	$0	$0	1

2021 · 22 people listed · 9 paid, $4.2M · 493 employees · 13 volunteers

Name	Title	Hrs/wk	From org	From related	Other	Total	Orgs
ROBERT RUBIN PHD	CEO, PRESIDENT, DIRECTOR	38	$903,937	$0	$117,843	$1,021,780	3
SHANNON TOMA TREASURER	EXEC VP, COO/CFO	40	$748,043	$0	$38,617	$786,660	1
STEVEN BELINSKY VP ACADEMIC	RESEARCH / SR. SCIENTIST	40	$448,203	$0	$38,343	$486,546	1
JACOB MCDONALD	VP, APPLIED SCIENCE	40	$404,394	$0	$41,709	$446,103	2
KENT KIEHL	EXECUTIVE SCIENCE OFFICER	40	$371,711	$0	$38,646	$410,357	2
DAVID FLANDERS	VP, HUMAN RESOURCES	40	$312,114	$0	$34,896	$347,010	1
ANDREW MAYER	VP, INTERDISCIPLINARY SCIENCE	40	$267,726	$0	$40,543	$308,269	2
EDWARD BARRETT	SR. DIRECTOR, PHARMACOLOGY	40	$251,634	$0	$38,725	$290,359	2
FRANCES FULPS-LAUR	ASSISTANT SECRETARY (THRU 2/28/22)	6	$106,135	$0	$20,785	$126,920	2
JACKIE LOVELACE JOHNSON	CHAIRWOMAN OF THE BOARD	2	$0	$0	$0	$0	3
JANE DELGADO DIR VICE CHAIR	OF NOMINATING COMMITTEE	2	$0	$0	$0	$0	1
CHRIS SPENCER CPA DIR CHAIR	BUDGET & FINANCE COMMITTEE	2	$0	$0	$0	$0	1
PAMELA SULLIVAN DIR CHAIR	AUDIT & COMPENSATION COMMITTEE	2	$0	$0	$0	$0	1
GREGORY DOWNEY MD	DIRECTOR	2	$0	$0	$0	$0	1
J GRANT BURCHAM	DIRECTOR	2	$0	$0	$0	$0	1
MAJOR GENERAL JOHN DOESBURG	DIRECTOR	2	$0	$0	$0	$0	1
MELVIN TWIEST MD	DIRECTOR	2	$0	$0	$0	$0	1
SARA EASTERSON-BOND	DIRECTOR	2	$0	$0	$0	$0	2
TESS BURLESON	DIRECTOR	2	$0	$0	$0	$0	2
RICHARD GILL PHD	DIRECTOR (THRU 4/25/22)	2	$0	$0	$0	$0	1
SANDRA CHAVEZ	DIRECTOR	2	$0	$0	$0	$0	1
TERRY DUNLAY	DIRECTOR	2	$0	$0	$0	$0	1

2020 · 24 people listed · 11 paid, $4.3M · 470 employees · 13 volunteers

Name	Title	Hrs/wk	From org	From related	Other	Total	Orgs
ROBERT RUBIN PHD	CEO, PRESIDENT, DIRECTOR	38	$863,089	$0	$37,382	$900,471	3
SHANNON TOMA TREASURER	EXEC VP, COO/CFO	38	$657,749	$0	$38,139	$695,888	1
STEVEN BELINSKY VP ACADEMIC	RESEARCH / SR. SCIENCE	40	$370,783	$0	$37,825	$408,608	1
KENT KIEHL	EXECUTIVE SCIENCE OFFICER	40	$346,184	$0	$38,167	$384,351	2
JACOB MCDONALD	VP, APPLIED SCIENCE	40	$332,734	$0	$41,297	$374,031	2
SCOTT THATCHER	VP, FINANCE (THROUGH JAN 2021)	40	$293,253	$0	$38,046	$331,299	1
DAVID FLANDERS	VP, HUMAN RESOURCES	40	$270,576	$0	$32,180	$302,756	1
ANDREW MAYER	VP, INTERDISCIPLINARY SCIENCE	40	$247,160	$0	$38,502	$285,662	2
EDWARD BARRETT	SR. DIRECTOR, PHARMACOLOGY	40	$219,961	$0	$35,536	$255,497	2
MELANIE DOYLE-EISELE	SR. DIRECTOR, LIFE SCIENCES	40	$209,350	$0	$30,575	$239,925	2
FRANCES FULPS-LAUR	ASSISTANT SECRETARY	6	$100,127	$0	$19,711	$119,838	2
JACKIE LOVELACE JOHNSON	CHAIRPERSON OF THE BOARD	2	$0	$0	$0	$0	3
JANE DELGADO DIR VICE CHAIR	OF NOMINATING COMMITTEE	2	$0	$0	$0	$0	1
CHRIS SPENCER CPA DIR CHAIR	BUDGET & FINANCE COMMITTEE	2	$0	$0	$0	$0	1
PAMELA SULLIVAN DIR CHAIR	AUDIT & COMPENSATION COMMITTEE	2	$0	$0	$0	$0	1
GREGORY DOWNEY MD	DIRECTOR	2	$0	$0	$0	$0	1
J GRANT BURCHAM	DIRECTOR	2	$0	$0	$0	$0	1
MAJOR GENERAL JOHN DOESBURG	DIRECTOR	2	$0	$0	$0	$0	1
MELVIN TWIEST MD	DIRECTOR	2	$0	$0	$0	$0	1
SARA EASTERSON-BOND	DIRECTOR	2	$0	$0	$0	$0	2
TESS BURLESON	DIRECTOR	2	$0	$0	$0	$0	2
RICHARD GILL PHD	DIRECTOR	2	$0	$0	$0	$0	1
SANDRA CHAVEZ	DIRECTOR	2	$0	$0	$0	$0	1
TERRY DUNLAY	DIRECTOR	2	$0	$0	$0	$0	1

2019 · 22 people listed · 8 paid, $2.6M · 33 employees · 13 volunteers

Name	Title	Hrs/wk	From org	From related	Other	Total	Orgs
ROBERT RUBIN PHD	CEO, PRESIDENT, DIRECTOR	38	$0	$828,760	$117,312	$946,072	3
SHANNON TOMA	TREASURER, EXEC VP, COO, C	38	$621,304	$0	$28,786	$650,090	3
DAVID FLANDERS	HUMAN RESOURCES VP	40	$209,023	$0	$26,618	$235,641	1
CHESTER LEACH	SCIENTIST EMERITUS	4	$209,608	$0	$912	$210,520	1
NANDAKUMAR RANGANATHAN	DIRECTOR OF IT	40	$148,744	$0	$15,493	$164,237	1
MARGARET MCMULLEN	BUS DEV OPS MANAGER	40	$133,376	$0	$14,276	$147,652	1
BUFFIE KERSTETTER	BUSINESS DEVELOP MANAGER	40	$129,116	$0	$11,385	$140,501	1
FRANCES LAUR	ASSISTANT SECRETARY	6	$98,460	$0	$11,416	$109,876	2
JACKIE LOVELACE JOHNSON	CHAIRPERSON OF THE BOARD	2	$0	$0	$0	$0	3
JANE DELGADO DIR VICE CHAIR	CHAIR OF NOMINATING COMMITTEE	2	$0	$0	$0	$0	1
CHRIS SPENCER CPA DIR CHAIR	BUDGET & FINANCE COMMITTEE	2	$0	$0	$0	$0	1
PAMELA SULLIVAN DIR CHAIR	AUDIT & COMPENSATION COMMI	2	$0	$0	$0	$0	1
GREGORY DOWNEY MD	DIRECTOR	2	$0	$0	$0	$0	1
J GRANT BURCHAM	DIRECTOR	2	$0	$0	$0	$0	1
MAJOR GENERAL JOHN DOESBURG	DIRECTOR	2	$0	$0	$0	$0	1
MELVIN TWIEST MD	DIRECTOR	2	$0	$0	$0	$0	1
AUGUSTINE CHOI MD	DIRECTOR (THROUGH DECEMBER 2019)	2	$0	$0	$0	$0	1
SARA EASTERSON-BOND	DIRECTOR	2	$0	$0	$0	$0	2
TESS BURLESON	DIRECTOR	2	$0	$0	$0	$0	2
RICHARD GILL PHD	DIRECTOR	2	$0	$0	$0	$0	1
SANDRA CHAVEZ	DIRECTOR	2	$0	$0	$0	$0	1
TERRY DUNLAY	DIRECTOR	2	$0	$0	$0	$0	1

2017 · 25 people listed · 7 paid, $2.1M · 58 employees · 15 volunteers

Name	Title	Hrs/wk	From org	From related	Other	Total	Orgs
ROBERT RUBIN PHD	CEO, PRESIDENT, DIRECTOR	2	$0	$698,337	$40,270	$738,607	3
SHANNON TOMA	TREASURER, COO, CFO	2	$318,403	$0	$40,172	$358,575	3
MATTHEW REED THROUGH 0318	DIR PRECILIN DRUG DEV/SCIENTIST	40	$208,529	$0	$34,111	$242,640	1
ERICA SMITH	SR. DIR. COM SALES & MARK	40	$190,244	$0	$20,057	$210,301	1
DAVID FLANDERS	HUMAN RESOURCES VICE PRESI	40	$177,206	$0	$24,201	$201,407	1
CHESTER LEACH	SCIENTIST EMERITUS	16	$146,278	$0	$12,119	$158,397	1
MARGARET DUNBAR THROUGH - 0817	GNRL CNSL & SR DIR OF BUS	40	$133,634	$0	$21,030	$154,664	1
JACKIE LOVELACE JOHNSON	CHAIRMAN OF THE BOARD	2	$0	$0	$0	$0	3
JAMES SWENBERG DVMPHD THRU 048	DIR, CHAIR - RESEARCH PROGRAMS	2	$0	$0	$0	$0	1
JANE DELGADO	DIR, CHAIR - NOMINATING CO	2	$0	$0	$0	$0	1
CHRIS SPENCER CPA	DIR, CHAIR - BUDGET & FINA	2	$0	$0	$0	$0	2
PAMELA SULLIVAN	DIR, CHAIR - AUDIT & COMPE	2	$0	$0	$0	$0	1
DAVID DURGIN THROUGH 0418	DIR, CHAIR - ALTERNATIVE	2	$0	$0	$0	$0	1
GREGORY DOWNEY MD	DIRECTOR	2	$0	$0	$0	$0	1
J GRANT BURCHAM	DIRECTOR	2	$0	$0	$0	$0	1
JACK MCCARTHY MD	DIRECTOR	2	$0	$0	$0	$0	1
JOE FULCHER THROUGH 1017	DIRECTOR	2	$0	$0	$0	$0	1
MAJOR GENERAL JOHN DOESBURG	DIRECTOR	2	$0	$0	$0	$0	1
MELVIN TWIEST MD	DIRECTOR	2	$0	$0	$0	$0	1
AUGUSTINE CHOI MD	DIRECTOR	2	$0	$0	$0	$0	1
SARA EASTERSON-BOND	DIRECTOR	2	$0	$0	$0	$0	2
TESS BURLESON	DIRECTOR	2	$0	$0	$0	$0	2
RICHARD GILL PHD	DIRECTOR	2	$0	$0	$0	$0	1
SANDRA CHAVEZ	DIRECTOR	2	$0	$0	$0	$0	1
TERRY DUNLAY	DIRECTOR	2	$0	$0	$0	$0	1

2016 · 27 people listed · 9 paid, $2.9M · 62 employees · 18 volunteers

Name	Title	Hrs/wk	From org	From related	Other	Total	Orgs
Robert Rubin PHD	CEO, President, Director	2	$0	$1,213,540	$41,105	$1,254,645	3
Shannon Toma	Treasurer, COO, CFO	42	$299,446	$0	$37,767	$337,213	3
Chester Leach	Scientist Emeritus	16	$219,166	$0	$10,089	$229,255	1
Matthew Reed	Dir PreClin Drug Dev/Scientist	40	$193,938	$0	$31,392	$225,330	1
Margaret Dunbar Throug - 08252017	Gnrl Cnsl & SR Dir of Bus Affa- Former	40	$180,467	$0	$26,170	$206,637	1
David Flanders	Human Resources Vice President	40	$173,462	$0	$22,730	$196,192	1
David Byrd through- 041917	CFO	2	$157,834	$0	$17,813	$175,647	1
Lucille Maestas Former - 012717	Assoc Director of ORC and PMO - Former	40	$142,683	$0	$15,208	$157,891	1
Julie Nickerson Former - 121916	Controller - Former	40	$138,779	$0	$18,322	$157,101	1
Jackie Lovelace Johnson	Chairman of the Board	2	$0	$0	$0	$0	3
James Swenberg DVM PHD	Dir, Chair - Research Program Oversight	2	$0	$0	$0	$0	1
Jane Delgado	Dir, Chair - Nominating Committee	2	$0	$0	$0	$0	1
Chris Spencer CPA	Dir, Chair - Budget & Finance	2	$0	$0	$0	$0	2
Pamela Sullivan	Dir, Chair - Audit & Compensation Committee	2	$0	$0	$0	$0	1
David Durgin	Dir, Chair - Alternative Investment Committee	2	$0	$0	$0	$0	1
Gregory Downey MD	Director	2	$0	$0	$0	$0	1
J Grant Burcham	Director	2	$0	$0	$0	$0	1
Jack McCarthy MD	Director	2	$0	$0	$0	$0	1
Joe Fulcher	Director	2	$0	$0	$0	$0	1
Major General John Doesburg	Director	2	$0	$0	$0	$0	1
Melvin Twiest MD	Director	2	$0	$0	$0	$0	1
Augustine Choi MD	Director	2	$0	$0	$0	$0	1
Sara Easterson-Bond	Director	2	$0	$0	$0	$0	2
Tess Burleson	Director	2	$0	$0	$0	$0	2
Richard Gill PHD	Director	2	$0	$0	$0	$0	1
Sandra Chavez	Director	2	$0	$0	$0	$0	1
Terry Dunlay	Director	2	$0	$0	$0	$0	1

2012 · 31 people listed · 11 paid, $2.5M · 95 employees · 20 volunteers

Name	Title	Hrs/wk	From org	From related	Other	Total	Orgs
DR ROBERT RUBIN	CEO/PRESIDENT	40	$635,353	$0	$96,659	$732,012	3
RICHARD MCGIVNEY THROUGH MID-2013	CHIEF FINANCIAL OFFICER	40	$235,109	$0	$27,538	$262,647	1
CHERYL DEVAUL	CHIEF HUMAN RESOURCES OFFICER	40	$212,224	$0	$24,539	$236,763	2
MATTHEW REED	DIRECTOR PRECLINICAL DRUG DEVELOPMENT/SCIENTIST	40	$197,482	$0	$21,366	$218,848	1
CHRISTOPHER MERRIAM-LEITH	DIRECTOR OF BUSINESS AFFAIRS	40	$166,717	$0	$17,669	$184,386	1
GARY LARUE THROUGH DECEMBER 2013	CORPORATE CONTROLLER	40	$160,654	$0	$18,666	$179,320	1
LORETTA GUERRA	DIRECTOR HUMAN RESOURCES	40	$159,633	$0	$18,957	$178,590	1
RACHEL M BLEA	DIRECTOR OF ITS	40	$151,381	$0	$14,479	$165,860	1
MICHAEL K SILBER	PROGRAM MANAGER, ERP	40	$118,063	$0	$13,148	$131,211	1
NANCY L CROWLEY	SENIOR PROGRAMMER/ANALYST	40	$115,739	$0	$14,529	$130,268	1
FRANCES LAUR	RECORDING/ASSISTANT SECRETARY	40	$108,909	$0	$11,433	$120,342	2
JACQUELINE LOVELACE JOHNSON	CHAIR, BOARD OF DIRECTORS	2	$0	$0	$0	$0	2
JAMES SWENBERG DVM PHD	VICE CHAIR & CHAIR RESEARCH PROGRAM OVERSIGNT COMM	2	$0	$0	$0	$0	1
FRANK BOND	VICE CHAIR & CHAIR NOMINATING COMMITTEE	2	$0	$0	$0	$0	1
JUDY JONES	SECRETARY	2	$0	$0	$0	$0	2
AUGUSTINE CHOI MD	DIRECTOR	2	$0	$0	$0	$0	1
CATHERINE SELLMAN	DIRECTOR	2	$0	$0	$0	$0	1
CHRISTOPHER SPENCER CPA	DIRECTOR	2	$0	$0	$0	$0	1
DAVID DURGIN	DIRECTOR	2	$0	$0	$0	$0	1
GREGORY DOWNEY MD	DIRECTOR	2	$0	$0	$0	$0	1
JACK MCCARTHY MD	DIRECTOR	2	$0	$0	$0	$0	1
JANE DELGADO PHD	DIRECTOR	2	$0	$0	$0	$0	1
JOE FULCHER	DIRECTOR	2	$0	$0	$0	$0	1
JOHN SHELTON	DIRECTOR	2	$0	$0	$0	$0	1
MAJOR GENERAL JOHN DOESBURG	DIRECTOR	2	$0	$0	$0	$0	1
MELVIN TWIEST	DIRECTOR	2	$0	$0	$0	$0	1
NORMAN CORZINE	DIRECTOR	2	$0	$0	$0	$0	2
PAMELA SULLIVAN	DIRECTOR	2	$0	$0	$0	$0	1
SARA EASTERSON-BOND MFA	DIRECTOR	2	$0	$0	$0	$0	1
W PHELPS ANDERSON	DIRECTOR	2	$0	$0	$0	$0	1
SHANNON TOMA	CHIEF FINANCIAL OFFICER	40	$0	$0	$0	$0	3

2011 · 31 people listed · 12 paid, $2.7M · 121 employees · 19 volunteers

Name	Title	Hrs/wk	From org	From related	Other	Total	Orgs
DR ROBERT RUBIN	PRESIDENT	40	$618,895	$0	$79,755	$698,650	3
RICHARD MCGIVNEY	CHIEF FINANCIAL OFFICER	40	$219,712	$0	$34,390	$254,102	1
CHERYL DEVAUL	CHIEF HUMAN RESOURCES OFFICER	40	$200,530	$0	$27,330	$227,860	2
MATTHEW REED	DIRECTOR PRECLINICAL DRUG DEVELOPMENT/SCIENTIST	40	$179,941	$0	$30,938	$210,879	1
CHESTER LEACH JR	SCIENTIST EMERITUS	40	$178,542	$0	$8,509	$187,051	1
CHRISTOPHER MERRIAM-LEITH	DIRECTOR OF BUSINESS AFFAIRS	40	$162,933	$0	$13,838	$176,771	1
LORETTA GUERRA	DIRECTOR HUMAN RESOURCES	40	$153,946	$0	$20,415	$174,361	1
GARY LARUE	CORPORATE CONTROLLER	40	$143,472	$0	$26,856	$170,328	1
WILLIAM BECHTOLD	DIRECTOR TECHNOLOGY TRANSFER	40	$144,236	$0	$24,615	$168,851	1
RACHEL BLEA	DIRECTOR OF ITS	40	$120,467	$0	$20,064	$140,531	1
NANCY CROWLEY	SENIOR PROGRAMMING ANALYST	40	$118,766	$0	$12,879	$131,645	1
FRANCES FELPS-LAUR	RECORDING/ASSISTANT SECRETARY	40	$92,045	$0	$19,276	$111,321	1
FRANK BOND	VICE CHAIR & CHAIR NOMINATING COMMITTEE	2	$0	$0	$0	$0	1
JACQUELINE LOVELACE JOHNSON	CHAIR	2	$0	$0	$0	$0	2
JUDY JONES	SECRETARY	2	$0	$0	$0	$0	2
JAMES SWENBERG DVM PHD	VICE CHAIR & CHAIR RESEARCH PROGRAM OVERSIGNT COMM	2	$0	$0	$0	$0	1
W PHELPS ANDERSON	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
AUGUSTINE CHOI MD	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
NORMAN CORZINE	BOARD OF DIRECTORS	2	$0	$0	$0	$0	2
JANE DELGADO PHD	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
MAJOR GENERAL JOHN DOESBURG	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
GREGORY DOWNEY MD	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
DAVID DURGIN	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
SARA EASTERSON-BOND MFA	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
JOE FULCHER	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
JACK MCCARTHY MD	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
CATHERINE SELLMAN	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
JOHN SHELTON	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
CHRISTOPHER SPENCER CPA	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
PAMELA SULLIVAN	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
MELVIN TWIEST	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1

2010 · 32 people listed · 10 paid, $2.3M · 115 employees · 23 volunteers

Name	Title	Hrs/wk	From org	From related	Other	Total	Orgs
DR ROBERT RUBIN	PRESIDENT	40	$621,899	$0	$36,705	$658,604	3
PATRICIA MARX	VICE PRESIDENT	40	$0	$329,947	$34,796	$364,743	2
RICHARD MCGIVNEY	TREASURER	40	$217,633	$0	$33,627	$251,260	1
CHERYL N DEVAUL	CHIEF HUMAN RESOURCES OFFICER	40	$193,401	$0	$28,305	$221,706	2
WILLIAM E BECHTOLD	DIRECTOR, TECHNICAL TRANSFERS	40	$139,087	$0	$23,406	$162,493	1
GARY LARUE	CONTROLLER	40	$135,356	$0	$24,978	$160,334	1
JOE MAUDERLY	VICE PRESIDENT	40	$0	$116,655	$19,427	$136,082	2
NANCY CROWLEY	SENIOR PROGRAMMER/ANALYST	40	$116,136	$0	$12,787	$128,923	1
MICHAEL K SILBER	PROGRAM MANAGER, ERP	40	$105,139	$0	$21,922	$127,061	1
FRANCES LAUR	RECORDING/ASSISTANT SECRETARY	40	$89,078	$0	$17,910	$106,988	2
JOHN SHELTON	SECRETARY	2	$0	$0	$0	$0	1
FRANK BOND	VICE CHAIR & CHAIR NOMINATING COMMITTEE	2	$0	$0	$0	$0	1
PATRICIA BUFFLER	VICE CHAIR AND CHAIR RESEARCH PROGRAM OVERSIGHT CO	2	$0	$0	$0	$0	1
JACKIE LOVELACE JOHNSON	CHAIR	2	$0	$0	$0	$0	3
SONIA BUIST	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
NORM CORZINE	BOARD OF DIRECTORS	2	$0	$0	$0	$0	2
JANE DELGADO PHD	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
JOE RG FULCHER JD	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
MARTIN HICKEY MD	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
JUDY K JONES	BOARD OF DIRECTORS	2	$0	$0	$0	$0	2
POPE MOSELY MD MS	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
BARBARA ROGERS	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
ERNEST ROMERO	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
DONALD E KILGORE JR MD	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
W PHELPS ANDERSON	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
JACK D MCCARTHY MD	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
MELVIN TWIEST MD	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
LISA GUILLERMIN GABLE	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
JAMES A SWENBERG DVM PHD	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
PAM SULLIVAN	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
MAJOR GENERAL JOHN DOESBURG	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1
DAVID L DURGIN	BOARD OF DIRECTORS	2	$0	$0	$0	$0	1

2009 · 29 people listed · 8 paid, $2.0M · 366 employees · 21 volunteers

Name	Title	Hrs/wk	From org	From related	Other	Total	Orgs
Robert W Rubin PhD	president/ceo	40	$594,254	$0	$68,532	$662,786	3
Patricia J Marx	vice president/COO	40	$321,734	$0	$23,881	$345,615	2
Richard C McGivney CPA	Treasurer/CFO	40	$210,727	$0	$20,453	$231,180	1
Cheryl DeVaul	Chief Human Resources Offi	40	$176,774	$0	$17,058	$193,832	2
Gary LaRue	Controller	40	$139,280	$0	$13,309	$152,589	1
William Bechtold	Director, Technology Trans	40	$135,508	$0	$12,931	$148,439	1
Nancy Crowley	IT Manager	40	$118,995	$0	$11,280	$130,275	1
Frances Laur	Asst Secretary	40	$86,833	$0	$8,064	$94,897	2
Jackie Lovelace Johnson	DirECTOR	2	$0	$0	$0	$0	3
Phelps Anderson	DirECTOR	2	$0	$0	$0	$0	1
Patricia Buffler PhD	DirECTOR	2	$0	$0	$0	$0	1
Norm Corzine	DIRECTOR	2	$0	$0	$0	$0	2
John Doesburg	DIRECTOR	2	$0	$0	$0	$0	1
David Durgin	DIRECTOR	2	$0	$0	$0	$0	1
Lisa Guillermin Gable	DIRECTOR	2	$0	$0	$0	$0	1
Martin Hickey	DIRECTOR	2	$0	$0	$0	$0	1
Don Kilgore Jr MD	DIRECTOR	2	$0	$0	$0	$0	1
Pope Moseley MD	DIRECTOR	2	$0	$0	$0	$0	1
Barbara Rogers	DIRECTOR	2	$0	$0	$0	$0	1
Ernie Romero	DIRECTOR	2	$0	$0	$0	$0	1
John Shelton	DIRECTOR	2	$0	$0	$0	$0	1
Pam Sullivan	DIRECTOR	2	$0	$0	$0	$0	1
James Swenberg	Director	2	$0	$0	$0	$0	1
Melvin Twiest MD	Director	2	$0	$0	$0	$0	1
Frank Bond	Director	2	$0	$0	$0	$0	1
Jane Delgado	Director	2	$0	$0	$0	$0	1
Joe Fulcher JD	DIRECTOR	2	$0	$0	$0	$0	1
Judy Jones	DIRECTOR	2	$0	$0	$0	$0	2
Jack McCarthy	DirECTOR	2	$0	$0	$0	$0	1

Highest-paid independent contractors

2024 · 5 contractors · $10.3M

Name	Location	Service	Paid
BRADBURY STAMM CONSTRUCTION INC	ALBUQUERQUE, NM	CONSTRUCTION SERVICES	$6,965,236
SUMMIT CONSTRUCTION INC	ALBUQUERQUE, NM	CONSTRUCTION SERVICES	$1,396,279
NCA ARCHITECTS LLC	ALBUQUERQUE, NM	CONSTRUCTION SERVICES	$1,228,877
UNIVERSAL PROTECTION SERVICES LP	OCEANSIDE, CA	OUTSOURCED SECURITY SERVICES	$512,279
MOSS ADAMS	ALBUQUERQUE, NM	ACCOUNTING SERVICES	$234,074

2023 · 5 contractors · $7.1M

Name	Location	Service	Paid
SUMMIT CONSTRUCTION INC	ALBUQUERQUE, NM	CONSTRUCTION SERVICES	$2,702,258
DKG AND ASSOCIATES INC	ALBUQUERQUE, NM	CONSTRUCTION SERVICES	$2,165,354
SDV CONSTRUCTION INC	ALBUQUERQUE, NM	CONSTRUCTION SERVICES	$1,463,133
UNIVERSAL PROTECTION SERVICES LP	CONSHOHOCKEN, PA	OUTSOURCED SECURITY SERVICES	$470,797
MOSS ADAMS	ALBUQUERQUE, NM	ACCOUNTING SERVICES	$254,307

2022 · 5 contractors · $7.7M

Name	Location	Service	Paid
SDV CONSTRUCTION INC	ALBUQUERQUE, NM	CONSTRUCTION SERVICES	$3,509,146
DKG AND ASSOCIATES INC	ALBUQUERQUE, NM	CONSTRUCTION SERVICES	$1,887,839
CAPSTONE CORPORATE FINANCE LLC	BOSTON, MA	BROKER	$1,516,411
UNIVERSAL PROTECTION SERVICES LP	CONSHOHOCKEN, PA	OUTSOURCED SECURITY SERVICES	$420,174
SUMMIT CONSTRUCTION INC	ALBUQUERQUE, NM	CONSTRUCTION SERVICES	$399,097

2021 · 5 contractors · $1.8M

Name	Location	Service	Paid
SDV CONSTRUCTION INC	ALBUQUERQUE, NM	CONSTRUCTION SERVICES	$438,585
SUMMIT CONSTRUCTION INC	ALBUQUERQUE, NM	CONSTRUCTION SERVICES	$426,473
UNIVERSAL PROTECTION SERVICES LP	CONSHOHOCKEN, PA	OUTSOURCED SECURITY SERVICES	$393,123
KCAS LLC	SHAWNEE, KS	DATA ANALYSIS	$310,530
KPMG LLP	DALLAS, TX	AUDIT SERVICES	$201,175

2020 · 5 contractors · $1.3M

Name	Location	Service	Paid
UNIVERSAL PROTECTION SERVICES LP	CONSHOHOCKEN, PA	OUTSOURCED SECURITY SERVICES	$363,003
MOSS ADAMS LLP	ALBUQUERQUE, NM	ACCOUNTING AND TAX SERVICES	$359,197
AIT BIOSCIENCES LLC	INDIANAPOLIS, IN	DATA ANALYSIS	$228,607
KPMG LLP	DALLAS, TX	AUDIT SERVICES	$182,323
IDEXX DISTRIBUTION INC	WESTBROOK, ME	DATA ANALYSIS	$182,096

2019 · 3 contractors · $1.3M

Name	Location	Service	Paid
MOSS ADAMS LLP	ALBUQUERQUE, NM	CONSULTANT	$901,061
CAPSTONE CORPORATE FINANCE LLC	BOSTON, MA	PROFESSIONAL SERVICES	$271,512
KPMG LLP	DALLAS, TX	AUDIT	$126,537

2017 · 2 contractors · $644K

Name	Location	Service	Paid
CLIFTONLARSONALLEN LLP	ALBUQUERQUE, NM	ACCOUNTING SERVICES	$475,710
MOSS ADAMS LLP	ALBUQUERQUE, NM	AUDIT, TAX RETURN PREPARATION	$168,721

2016 · 5 contractors · $887K

Name	Location	Service	Paid
Moss Adams LLP	Albuquerque, NM	Audit, Tax Return Preparation	$283,031
CMGRP Inc DBA Cassidy & Associates	Washington, DC	Lobbying	$207,643
Sabio Systems	Albuquerque, NM	Staffing Company	$178,491
Robert Half Technology	San Francisco, CA	Staffing Company	$118,217
Kinetek Consulting LLC	Weston, FL	Consulting	$100,085

2012 · 5 contractors · $1.2M

Name	Location	Service	Paid
ROBERT HALF INTERNATIONAL	LOS ANGELES, CA	TEMPORARY STAFFING / RECRUITING	$333,461
QUALITY MANAGEMENT SERVICES LLC	FREDERICK, MD	TRAINING	$317,207
ERNST & YOUNG	MCLEAN, VA	PROFESSIONAL SERVICES	$253,241
CASSIDY & ASSOCIATES	WASHINGTON, DC	LOBBYING SERVICES	$208,523
KINETEK CONSULTING LLC	WESTON, FL	CONSULTING	$127,568

2011 · 5 contractors · $1.9M

Name	Location	Service	Paid
ERNST & YOUNG	PHILADELPHIA, PA	CONSULTING	$977,108
EVCO PARTNERS LP DBA BURGOON COMPANY	GALVASTON, TX	EQUIPMENT AND SUPPLIES	$336,518
QUALITY MANAGEMENT SERVICES LLC	FREDERICK, MD	TRAINING	$248,590
PRECISION X-RAY	N BRANFORD, CT	EQUIPMENT	$170,171
SEMFIN GROUP LLC	MCLEAN, VA	CONSULTING	$145,248

2010 · 5 contractors · $2.8M

Name	Location	Service	Paid
GERALD MARTIN	ALBUQUERQUE, NM	CONSTRUCTION	$1,315,285
ERNST & YOUNG	PHILADELPHIA, PA	CONSULTING	$882,895
LOCKTON INSURANCE BROKERS	LOS ANGELES, CA	INSURANCE	$239,562
QUALITY MANAGEMENT SERVICES LLC	FREDERICK, MD	TRAINING	$201,424
SEMFIN GROUP LLC	MCLEAN, VA	CONSULTING	$143,848

2009 · 5 contractors · $2.6M

Name	Location	Service	Paid
Gerald Martin LTD	Albuquerque, NM	Construction Services	$1,654,654
Global Research Supply	Reno, NV	Supplies	$465,160
Meyners Company LLC	Albuquerque, NM	Audit Services	$196,324
Ernst & Young	New York, NY	Subcontract Services	$155,127
Southern California Series of Lockton	Kansas City, MO	Insurance	$132,195

Who gave

Contributor names are not public for this form type.

Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.

Finances

Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.

Revenue	Expenses	Assets	Net assets	Contributions	Program revenue	Officer pay	Employees	Volunteers
2024 · Form 990 period ending 2025-06-30 · view filing · original 990 ↗
$83,397,041	$87,744,696	$255,478,512	$207,161,613	$12,194,618	$63,041,316	$1,718,514	495	6
2023 · Form 990 period ending 2024-06-30 · view filing · original 990 ↗
$91,209,797	$91,486,502	$256,421,032	$212,022,844	$10,571,681	$77,674,822	$1,798,512	531	10
2022 · Form 990 period ending 2023-06-30 · view filing · original 990 ↗
$112,131,523	$94,680,185	$259,201,284	$207,334,520	$12,759,726	$97,269,762	$2,470,362	503	9
2021 · Form 990 period ending 2022-06-30 · view filing · original 990 ↗
$71,507,956	$66,188,457	$184,740,544	$120,606,119	$8,132,918	$62,508,220	$1,746,390	493	13
2020 · Form 990 period ending 2021-09-24 · view filing · original 990 ↗
$89,255,628	$80,362,730	$189,542,168	$129,294,967	$12,922,849	$74,903,418	$2,635,782	470	13
2019 · Form 990 period ending 2020-09-25 · view filing · original 990 ↗
$76,388,415	$74,188,991	$159,558,180	$110,727,486	$14,011,130	$58,650,412	$1,669,682	33	13
2017 · Form 990 period ending 2018-09-28 · view filing · original 990 ↗
$17,520,714	$15,989,123	$62,218,262	$30,404,585	$52,159	$14,518,227	$478,808	58	15
2016 · Form 990 period ending 2017-09-29 · view filing · original 990 ↗
$10,540,044	$20,559,896	$61,729,283	$29,052,005	$65	$9,493,238	$1,236,911	62	18
2012 · Form 990 period ending 2013-09-30 · view filing · original 990 ↗
$41,414,093	$38,265,599	$127,405,466	$98,232,773	$28,445,094	$10,715,693	$2,125,552	95	20
2011 · Form 990 period ending 2012-09-30 · view filing · original 990 ↗
$51,879,538	$49,699,380	$124,569,232	$93,968,711	$39,436,904	$9,633,052	$1,806,416	121	19
2010 · Form 990 period ending 2011-09-30 · view filing · original 990 ↗
$58,300,616	$44,352,653	$113,814,013	$82,405,891	$46,635,895	$10,822,270	$1,867,255	115	23
2009 · Form 990 period ending 2010-09-30 · view filing · original 990 ↗
$17,489,887	$20,455,248	$95,150,604	$70,692,180	$1,035,959	$15,398,763	$1,213,549	366	21

Connected to

Organizations that list some of the same people on their returns (officers, directors, key employees on this organization’s latest return), and related organizations it lists on Schedule R.

LOVELACE BIOMEDICAL & ENVIRONMENTAL Albuquerque, NM · 5 people in common (Jackie Lovelace Johnson, Melanie Doyle-Eisele, Robert W Rubin Phd)
THE MIND RESEARCH NETWORK Albuquerque, NM · 4 people in common (Jackie Lovelace Johnson, Kent Kiehl, Robert W Rubin Phd)
TOURO UNIVERSITY New York, NY · 3 people in common (Dr Alan Kadish, Margaret Retter, Salomon Amar) · related organization (Schedule R)
TOURO UNIVERSITY Vallejo, CA · 3 people in common (Dr Alan Kadish, Margaret Retter, Salomon Amar) · related organization (Schedule R)
TOURO UNIVERSITY NEVADA Drive Henderson, NV · 3 people in common (Dr Alan Kadish, Margaret Retter, Salomon Amar)
NEW YORK MEDICAL COLLEGE Valhalla, NY · 2 people in common (Dr Alan Kadish, Salomon Amar)
FOOT CENTER OF NEW YORK New York, NY · 2 people in common (Dr Alan Kadish, Margaret Retter)
BIOTECHNOLOGY INCUBATOR AT NYMC INC Valhalla, NY · 2 people in common (Dr Alan Kadish, Salomon Amar) · related organization (Schedule R)
TOURO COLLEGE & UNIVERSITY SYSTEM INC New York, NY · 1 person in common (Dr Alan Kadish) · related organization (Schedule R)
TOURO UNIVERSITY MEDICAL GROUP New York, NY · 1 person in common (Dr Alan Kadish)
NEW YORK COLLEGE OF PODIATRIC MEDICINE New York, NY · 1 person in common (Dr Alan Kadish)
MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES Great Falls, MT · 1 person in common (Dr Alan Kadish)
NYMC - SCHOOL OF MEDICINE FACULTY PRACTICE CORPORATION Valhalla, NY · 1 person in common (Dr Alan Kadish) · related organization (Schedule R)
NYMC LLC New York, NY · 1 person in common (Dr Alan Kadish) · related organization (Schedule R)
TOURO LAW CENTER DEVELOPMENT FOUNDATION INC New York, NY · related organization (Schedule R)
BARBARA & WILLIAM ROSENTHAL FOUNDATION Wilmington, DE · related organization (Schedule R)
PARTNERSHIP FOR A HEALTHY POPULATION INC New York, NY · related organization (Schedule R)
HEBREW THEOLOGICAL COLLEGE Skokie, IL · related organization (Schedule R)
YESHIVA RABBI DOV REVEL OF FOREST HILLS INC New York, NY · related organization (Schedule R)
YESHIVAS OHR HACHAIM New York, NY · related organization (Schedule R)

Funders of this organization

9 grantors reported grants to this organization, $14,289,050 in all, tax years 2009 to 2024. Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV

Grantor	Type	Match	Years given	Grants	Total	Latest year	Latest year's amount	Grants
HEALTH EFFECTS INSTITUTE	Public charity	Exact	2009-2014	6	$7,278,726	2014	$84,050	show
JOHNS HOPKINS UNIVERSITY	DAF sponsor	Exact	2009-2013, 2017-2020	9	$2,713,572	2020	$18,892	show
EMORY UNIVERSITY	Public charity	Exact	2014-2024	11	$1,291,919	2024	$135,273	show
MICHAEL J FOX FOUNDATION FOR PARKINSONS RESEARCH	Public charity	Exact	2015	1	$1,202,543	2015	$1,202,543	show
FOUNDATION FOR CHEMISTRY RESEARCH AND INITIATIVES	Public charity	Exact	2011-2014	4	$552,350	2014	$231,796	show
AMERICAN LUNG ASSOCIATION	Public charity	Exact	2009-2011, 2014-2015, 2022	6	$432,500	2022	$200,000	show
PRESIDENT AND FELLOWS OF HARVARD COLLEGE	DAF sponsor	Exact	2010-2012	3	$402,440	2012	$198,499	show
FIDELITY FOUNDATION	Private foundation	Fuzzy filed as “LOVELACE BIOMEDICAL RESEARCH INSTITUTE”	2021	1	$395,000	2021	$395,000	show
PATH VACCINE SOLUTIONS	Public charity	Exact	2012	1	$20,000	2012	$20,000	show

Nearby + Similar BETA

Organizations like this one: what they do and who they are linked to

Organizations like this one

Same category: NTEE code and revenue

Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. Same state only · More (100)

Organization	State	NTEE	Latest revenue	Latest expenses	Top-paid title	Top pay	Why similar
STOWERS INSTITUTE FOR MEDICAL RESEARCH	MO	H92	$102,011,512	$104,688,153	DIRECTOR/CHAIR DECEASED 3/27/25	$3,206,337	Same NTEE code H92, revenue within 2x, similar mission
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE	CA	H92	$114,401,821	$116,107,616	CEO & PRESIDENT	$1,345,526	Same NTEE code H92, revenue within 2x, similar mission
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON	WA	H92	$81,277,408	$80,732,627	CHIEF EXECUTIVE OFFICER VMFH	$5,754,859	Same NTEE code H92, revenue within 2x
OKLAHOMA MEDICAL RESEARCH FOUNDATION	OK	H92	$136,776,829	$126,476,987	EVP and Chief Medical Officer	$1,016,574	Same NTEE code H92, revenue within 2x
FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC	MD	H92	$78,507,209	$76,818,918	Chief Executive Officer	$689,835	Same NTEE code H92, revenue within 2x
GARY AND MARY WEST HEALTH INSTITUTE	CA	H92	$44,564,569	$42,453,440	CMO & EVP CLINICAL RESEARCH	$958,995	Same NTEE code H92, revenue within 2x
WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH	MA	H92	$222,267,487	$174,270,117	DIRECTOR/PRESIDENT	$1,081,921	Same NTEE code H92, revenue within 5x, similar name
SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH	WA	H92	$25,335,790	$25,203,489	DIRECTOR	$386,696	Same NTEE code H92, revenue within 5x, similar name
BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA	LA	H92	$25,307,433	$20,561,945	CEO/PRESIDENT	$814,733	Same NTEE code H92, revenue within 5x
SCRIPPS RESEARCH INSTITUTE	CA	H92	$698,624,318	$537,453,981	PRESIDENT/CEO	$1,859,240	Same NTEE code H92, revenue within 10x, similar name
MASONIC MEDICAL RESEARCH LABORATORY	NY	H92	$10,134,010	$11,033,378	EXECUTIVE DIRECTOR	$659,772	Same NTEE code H92, revenue within 10x, similar mission
STEADMAN PHILIPPON RESEARCH INSTITUTE	CO	H92	$14,151,760	$16,201,121	CHIEF SCIENTIFIC OFFICER	$661,826	Same NTEE code H92, revenue within 10x
JACKSON LABORATORY	ME	H92	$652,542,607	$617,013,316	PRESIDENT & CEO	$2,746,750	Same NTEE code H92, revenue within 10x
WASHINGTON RESEARCH FOUNDATION	WA	H92	$13,350,694	$23,039,321	PRESIDENT & CEO	$793,167	Same NTEE code H92, revenue within 10x
BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA	CA	H92	$141,627	$136,871	PRESIDENT AND CEO	$29,482	Same NTEE code H92, revenue differs more than 10x, similar mission
APPLIED BIOMEDICAL SCIENCE INSTITUTE	CA	H92	$4,539,463	$4,281,826	PROFESSOR	$223,011	Same NTEE code H92, revenue differs more than 10x, similar name
GLOBAL GENOMICS AND BIOINFORMATICS RESEARCH INSTITUTE	VA	H92	$494	$0	PRESIDENT	$0	Same NTEE code H92, revenue differs more than 10x
LIFESPAN RESEARCH INSTITUTION	CA	H92	$1,799,122	$6,520,518	Chief Executive Officer	$292,427	Same NTEE code H92, revenue differs more than 10x
PENNINGTON BIOMEDICAL RESEARCH FOUNDATION	LA	H92	$4,483,977	$4,163,749	CHIEF DEVELOPMENT OFFICER	$256,778	Same NTEE code H92, revenue differs more than 10x
FOUNDATION FOR BIOMEDICAL RESEARCH	DC	H92	$1,931,597	$1,205,880	PRESIDENT	$199,375	Same NTEE code H92, revenue differs more than 10x
WISCONSIN CORPORATION FOR BIOMEDICAL RESEARCH	WI	H92	$776,831	$490,153	BOARD MEMBER	$352,262	Same NTEE code H92, revenue differs more than 10x
IMAGE GUIDED THERAPY RESEARCH INSTITUTE	MD	H92	$77,000	$76,708	PRESIDENT	$0	Same NTEE code H92, revenue differs more than 10x
HOWARD HUGHES MEDICAL INSTITUTE	MD	H92	$2,004,784,057	$1,178,202,544	VP & CHIEF INVESTMENT OFFICER	$2,004,966	Same NTEE code H92, revenue differs more than 10x
BUFFALO INSTITUTE FOR MEDICAL RESEARCH INC	NY	H92	$991,228	$887,274	DIRECTOR	$434,775	Same NTEE code H92, revenue differs more than 10x, similar name
STATES UNITED FOR BIOMEDICAL RESEARCH INC	NC	H92	$26,200	$25,415	PRESIDENT	$0	Same NTEE code H92, revenue differs more than 10x

Who funds organizations like this

Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).

Grantor	Type	Total given	Grants	Organizations funded	Years	Which ones
SILICON VALLEY COMMUNITY FOUNDATION	DAF sponsor	$582,133,676	56	19	2010–2024	CHAN ZUCKERBERG BIOHUB INC; J DAVID GLADSTONE INSTITUTES; JACKSON LABORATORY; WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH and 15 more
GATES FOUNDATION	Private foundation	$483,729,983	199	15	2010–2024	SCRIPPS RESEARCH INSTITUTE; GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC; FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC; CRITICAL PATH INSTITUTE and 11 more
CHAN ZUCKERBERG INITIATIVE FOUNDATION	Private foundation	$382,645,983	11	1	2017–2024	CHAN ZUCKERBERG BIOHUB INC
ENTERTAINMENT INDUSTRY FOUNDATION	DAF sponsor	$301,431,733	17	4	2011–2024	AMERICAN ASSOCIATION FOR CANCER RESEARCH; INSTITUTE FOR CANCER RESEARCH; TRANSLATIONAL GENOMICS RESEARCH INSTITUTE; LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL
GARY AND MARY WEST HEALTH ENDOWMENTINC	Private foundation	$165,717,432	9	1	2014–2022	GARY AND MARY WEST HEALTH INSTITUTE
DECHOMAI FOUNDATION INC	DAF sponsor	$138,782,261	7	2	2021–2024	ARC RESEARCH INSTITUTE; ALZHEIMERS DISEASE RESEARCH FOUNDATION
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY	DAF sponsor	$76,659,000	12	2	2016–2024	MORGRIDGE INSTITUTE FOUNDATION INC; J DAVID GLADSTONE INSTITUTES
VANGUARD CHARITABLE ENDOWMENT PROGRAM	DAF sponsor	$75,101,847	74	24	2020–2024	ARC RESEARCH INSTITUTE; THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY; SCRIPPS RESEARCH INSTITUTE; PARKINSONS FOUNDATION INC and 20 more
FIDELITY INVESTMENTS CHARITABLE GIFT FUND	DAF sponsor	$70,964,620	204	35	2016–2024	ALZHEIMERS DISEASE RESEARCH FOUNDATION; SCRIPPS RESEARCH INSTITUTE; PARKINSONS FOUNDATION INC; FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC and 31 more
GARY AND MARY WEST CHARITABLE TRUST	Private foundation	$58,000,000	2	1	2023–2024	GARY AND MARY WEST HEALTH INSTITUTE
DONOR ADVISED CHARITABLE GIVING	DAF sponsor	$52,116,894	220	31	2014–2024	J DAVID GLADSTONE INSTITUTES; ARC RESEARCH INSTITUTE; ALZHEIMERS DISEASE RESEARCH FOUNDATION; SCRIPPS RESEARCH INSTITUTE and 27 more
LK WHITTIER FOUNDATION	Private foundation	$33,000,000	3	1	2020–2022	J DAVID GLADSTONE INSTITUTES
YALE UNIVERSITY	DAF sponsor	$32,625,398	112	17	2009–2024	THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH; SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE; HENNEPIN HEALTHCARE RESEARCH INSTITUTE; NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION INC and 13 more
NATIONAL PHILANTHROPIC TR	DAF sponsor	$29,424,444	126	30	2014–2024	ARC RESEARCH INSTITUTE; THE MEDICAL UNIVERSITY OF SOUTH CAROLINA FOUNDATION; STEADMAN PHILIPPON RESEARCH INSTITUTE; GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC and 26 more
JON AND KAREN HUNTSMAN FOUNDATION	Private foundation	$28,606,010	9	1	2014–2024	HUNTSMAN CANCER FOUNDATION

The full list · all similar organizations

Where the money went

Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.

2024 · Form 990 · $87,744,696 spent · pay $38,722,912 · grants $0 · events $160,505

Line	As described	Total	Program	Management	Fundraising	Share
Other salaries and wages		$25,739,405	$22,337,201	$3,402,204	-	29.3%
Other (as described)	RESEARCH SUPPLIES	$19,725,576	$19,681,149	$44,427	-	22.5%
Depreciation and depletion		$7,600,442	$6,765,141	$835,301	-	8.7%
Fees: other services		$6,842,617	$6,270,804	$571,813	-	7.8%
Other employee benefits		$6,790,340	$5,934,757	$855,583	-	7.7%
Occupancy		$3,634,153	$3,394,371	$239,782	-	4.1%
Pension plan contributions		$2,304,702	$2,000,069	$304,633	-	2.6%
Travel		$2,184,392	$1,572,534	$611,858	-	2.5%
Payroll taxes		$2,169,951	$1,883,129	$286,822	-	2.5%
All other expenses		$1,789,884	$1,789,884	-	-	2.0%
Pay: officers, directors, trustees, key employees		$1,718,514	-	$1,718,514	-	2.0%
Information technology		$1,622,893	$1,475,429	$147,464	-	1.8%
Other (as described)	REPAIRS AND MAINTENANCE	$1,610,166	$1,503,927	$106,239	-	1.8%
Insurance		$1,325,593	$1,212,558	$113,035	-	1.5%
Interest		$835,869	-	$835,869	-	1.0%
Other (as described)	NON-CAPITAL EQUIPMENT	$810,674	$757,301	$53,373	-	0.9%
Office expenses		$316,061	$295,206	$20,855	-	0.4%
Fees: accounting		$280,265	-	$280,265	-	0.3%
Conferences, conventions and meetings		$160,505	$140,901	$19,604	-	0.2%
Fees: investment management		$105,958	-	$105,958	-	0.1%
Fees: lobbying		$76,802	-	$76,802	-	0.1%
Advertising and promotion		$70,495	$70,495	-	-	0.1%
Fees: legal		$29,439	-	$29,439	-	0.0%
Total		$87,744,696				100%

View the filing

2023 · Form 990 · $91,486,502 spent · pay $36,877,596 · grants $0 · events $183,731

Line	As described	Total	Program	Management	Fundraising	Share
Other (as described)	RESEARCH SUPPLIES	$25,393,616	$25,393,616	-	-	27.8%
Other salaries and wages		$24,881,140	$22,144,215	$2,736,925	-	27.2%
Depreciation and depletion		$7,393,697	$7,319,760	$73,937	-	8.1%
Other employee benefits		$6,165,207	$5,795,295	$369,912	-	6.7%
Fees: other services		$5,787,066	$5,143,832	$643,234	-	6.3%
Other (as described)	REPAIRS AND MAINTENANCE	$4,466,972	$4,109,614	$357,358	-	4.9%
Occupancy		$3,568,713	$3,283,216	$285,497	-	3.9%
Payroll taxes		$2,117,367	$1,884,457	$232,910	-	2.3%
Pension plan contributions		$1,915,370	$1,704,679	$210,691	-	2.1%
Pay: officers, directors, trustees, key employees		$1,798,512	$145,293	$1,653,219	-	2.0%
Information technology		$1,768,103	$1,538,250	$229,853	-	1.9%
Travel		$1,744,975	$1,605,377	$139,598	-	1.9%
Insurance		$1,129,770	$994,198	$135,572	-	1.2%
Interest		$731,114	-	$731,114	-	0.8%
Other (as described)	NON-CAPITAL EQUIPMENT	$615,985	$560,546	$55,439	-	0.7%
All other expenses		$495,376	$495,376	-	-	0.5%
Fees: accounting		$394,955	-	$394,955	-	0.4%
Office expenses		$377,374	$347,184	$30,190	-	0.4%
Other (as described)	SHARED EMPLOYEE EXPENSE	$200,000	-	$200,000	-	0.2%
Conferences, conventions and meetings		$183,731	$143,310	$40,421	-	0.2%
Fees: investment management		$137,766	-	$137,766	-	0.2%
Advertising and promotion		$90,957	$78,223	$12,734	-	0.1%
Fees: lobbying		$69,500	-	$69,500	-	0.1%
Fees: legal		$59,236	-	$59,236	-	0.1%
Total		$91,486,502				100%

View the filing

2022 · Form 990 · $94,680,185 spent · pay $35,367,569 · grants $0 · events $282,522

Line	As described	Total	Program	Management	Fundraising	Share
Other (as described)	RESEARCH SUPPLIES	$33,826,529	$33,826,529	-	-	35.7%
Other salaries and wages		$19,433,767	$16,227,195	$3,206,572	-	20.5%
Other employee benefits		$9,465,908	$7,924,137	$1,541,771	-	10.0%
Depreciation and depletion		$7,089,866	$6,317,071	$772,795	-	7.5%
Fees: other services		$5,214,097	$4,116,104	$1,097,993	-	5.5%
Occupancy		$3,923,727	$3,339,092	$584,635	-	4.1%
Pay: officers, directors, trustees, key employees		$2,470,362	$404,128	$2,066,234	-	2.6%
Pension plan contributions		$2,073,049	$1,780,112	$292,937	-	2.2%
Other (as described)	REPAIRS AND MAINTENANCE	$2,047,021	$1,742,015	$305,006	-	2.2%
Payroll taxes		$1,924,483	$1,606,943	$317,540	-	2.0%
Information technology		$1,597,351	$1,389,695	$207,656	-	1.7%
Travel		$1,470,162	$1,004,121	$466,041	-	1.6%
Insurance		$1,113,133	$933,919	$179,214	-	1.2%
Interest		$698,935	-	$698,935	-	0.7%
Other (as described)	NON-CAPITAL EQUIPMENT	$605,228	$555,599	$49,629	-	0.6%
Fees: accounting		$401,055	-	$401,055	-	0.4%
Office expenses		$395,752	$328,078	$67,674	-	0.4%
Other (as described)	BAD DEBT	$325,061	$325,061	-	-	0.3%
Conferences, conventions and meetings		$282,522	$210,196	$72,326	-	0.3%
Fees: investment management		$110,633	-	$110,633	-	0.1%
Advertising and promotion		$89,327	$89,327	-	-	0.1%
Fees: lobbying		$64,380	-	$64,380	-	0.1%
Fees: legal		$40,905	-	$40,905	-	0.0%
All other expenses		$16,932	$16,932	-	-	0.0%
Total		$94,680,185				100%

View the filing

2021 · Form 990 · $66,188,457 spent · pay $25,557,620 · grants $0 · events $174,331

Line	As described	Total	Program	Management	Fundraising	Share
Other (as described)	RESEARCH SUPPLIES	$18,090,944	$18,090,944	-	-	27.3%
Other salaries and wages		$16,444,246	$12,974,510	$3,469,736	-	24.8%
Fees: other services		$6,665,555	$4,788,903	$1,876,652	-	10.1%
Other employee benefits		$4,540,840	$3,573,641	$967,199	-	6.9%
Other (as described)	REPAIRS AND MAINTENANCE	$4,315,545	$3,400,649	$914,896	-	6.5%
Depreciation and depletion		$3,631,342	$3,086,641	$544,701	-	5.5%
Occupancy		$2,614,387	$2,060,137	$554,250	-	3.9%
Pay: officers, directors, trustees, key employees		$1,746,390	$348,898	$1,397,492	-	2.6%
Payroll taxes		$1,445,542	$1,137,642	$307,900	-	2.2%
Pension plan contributions		$1,380,602	$1,086,534	$294,068	-	2.1%
Information technology		$1,084,998	$650,999	$433,999	-	1.6%
Other (as described)	NON-CAPITAL EQUIPMENT	$959,671	$704,399	$255,272	-	1.4%
Insurance		$666,266	$508,361	$157,905	-	1.0%
Interest		$556,716	-	$556,716	-	0.8%
Fees: accounting		$424,103	-	$424,103	-	0.6%
Other (as described)	BAD DEBT	$365,224	$365,224	-	-	0.6%
Office expenses		$300,361	$232,479	$67,882	-	0.5%
Travel		$256,093	$88,608	$167,485	-	0.4%
Fees: legal		$226,269	-	$226,269	-	0.3%
Conferences, conventions and meetings		$174,331	$137,198	$37,133	-	0.3%
Advertising and promotion		$96,957	$76,790	$20,167	-	0.1%
All other expenses		$84,097	$61,726	$22,371	-	0.1%
Fees: investment management		$70,818	-	$70,818	-	0.1%
Fees: lobbying		$47,160	-	$47,160	-	0.1%
Total		$66,188,457				100%

View the filing

2020 · Form 990 · $80,362,730 spent · pay $31,978,794 · grants $0 · events $69,309

Line	As described	Total	Program	Management	Fundraising	Share
Other (as described)	RESEARCH SUPPLIES	$20,275,099	$20,274,976	$123	-	25.2%
Other salaries and wages		$18,716,984	$17,400,722	$1,316,262	-	23.3%
Occupancy		$7,363,432	$5,576,316	$1,787,116	-	9.2%
Other employee benefits		$7,268,572	$3,604,685	$3,663,887	-	9.0%
Fees: other services		$7,164,758	$5,834,880	$1,329,878	-	8.9%
Depreciation and depletion		$5,015,780	$4,263,575	$752,205	-	6.2%
Information technology		$3,457,180	$2,056,325	$1,400,855	-	4.3%
Pay: officers, directors, trustees, key employees		$2,635,782	$393,600	$2,242,182	-	3.3%
Payroll taxes		$1,745,216	$297,502	$1,447,714	-	2.2%
Pension plan contributions		$1,612,240	$91,774	$1,520,466	-	2.0%
All other expenses		$1,368,678	$937,951	$430,727	-	1.7%
Fees: accounting		$933,411	-	$933,411	-	1.2%
Insurance		$917,138	$699,829	$217,309	-	1.1%
Interest		$813,405	-	$813,405	-	1.0%
Fees: legal		$304,485	-	$304,485	-	0.4%
Office expenses		$228,012	$177,220	$50,792	-	0.3%
Travel		$159,436	$55,137	$104,299	-	0.2%
Advertising and promotion		$144,262	$114,174	$30,088	-	0.2%
Conferences, conventions and meetings		$69,309	$53,108	$16,201	-	0.1%
Fees: lobbying		$62,880	-	$62,880	-	0.1%
Fees: investment management		$55,077	-	$55,077	-	0.1%
Other (as described)	BAD DEBT	$51,594	$51,594	-	-	0.1%
Total		$80,362,730				100%

View the filing

2019 · Form 990 · $74,188,991 spent · pay $31,278,062 · grants $0 · events $99,931

Line	As described	Total	Program	Management	Fundraising	Share
Other salaries and wages		$19,068,445	$17,533,188	$1,535,257	-	25.7%
Other (as described)	RESEARCH SUPPLIES	$16,088,659	$16,088,659	-	-	21.7%
Other employee benefits		$7,299,357	$1,244,299	$6,055,058	-	9.8%
Fees: other services		$7,291,760	$5,922,377	$1,369,383	-	9.8%
Occupancy		$5,249,554	$2,683,617	$2,565,937	-	7.1%
Depreciation and depletion		$4,761,077	$1,986,118	$2,774,959	-	6.4%
Information technology		$2,840,840	$1,677,900	$1,162,940	-	3.8%
All other expenses		$2,629,467	$2,193,413	$436,054	-	3.5%
Pay: officers, directors, trustees, key employees		$1,669,682	-	$1,669,682	-	2.3%
Pension plan contributions		$1,649,980	$113,893	$1,536,087	-	2.2%
Fees: accounting		$1,610,737	-	$1,610,737	-	2.2%
Payroll taxes		$1,590,598	$270,959	$1,319,639	-	2.1%
Interest		$952,291	-	$952,291	-	1.3%
Insurance		$730,081	$578,758	$151,323	-	1.0%
Travel		$244,707	$129,643	$115,064	-	0.3%
Office expenses		$155,551	$92,699	$62,852	-	0.2%
Fees: legal		$110,560	-	$110,560	-	0.1%
Conferences, conventions and meetings		$99,931	$72,346	$27,585	-	0.1%
Advertising and promotion		$95,160	$60,675	$34,485	-	0.1%
Fees: investment management		$45,474	-	$45,474	-	0.1%
Fees: lobbying		$5,080	-	$5,080	-	0.0%
Total		$74,188,991				100%

View the filing

2017 · Form 990 · $15,989,123 spent · pay $7,049,563 · grants $0 · events $68,137

Line	As described	Total	Program	Management	Fundraising	Share
Pay: disqualified persons		$4,433,778	$1,838,405	$2,595,373	-	27.7%
Other (as described)	RESEARCH SUPPLIES	$2,589,022	$2,589,022	-	-	16.2%
Fees: other services		$2,168,026	$1,734,048	$433,978	-	13.6%
Other employee benefits		$1,844,660	$911,742	$932,918	-	11.5%
Interest		$1,066,746	-	$1,066,746	-	6.7%
Information technology		$830,602	$263,831	$566,771	-	5.2%
Fees: accounting		$750,580	$41,280	$709,300	-	4.7%
Insurance		$698,883	-	$698,883	-	4.4%
Depreciation and depletion		$582,253	$456,862	$125,391	-	3.6%
Pay: officers, directors, trustees, key employees		$478,808	-	$478,808	-	3.0%
Office expenses		$375,657	$102,248	$273,409	-	2.3%
Payroll taxes		$240,393	$40,951	$199,442	-	1.5%
Occupancy		$179,431	$4,331	$175,100	-	1.1%
All other expenses		$164,979	$5,000	$159,979	-	1.0%
Travel		$134,532	$76,044	$58,488	-	0.8%
Fees: legal		$79,172	-	$79,172	-	0.5%
Other (as described)	SUPPLIES	$76,704	$51,881	$24,823	-	0.5%
Conferences, conventions and meetings		$68,137	$40,787	$27,350	-	0.4%
Pension plan contributions		$51,924	$3,467	$48,457	-	0.3%
Fees: investment management		$50,167	-	$50,167	-	0.3%
Advertising and promotion		$43,961	$3,028	$40,933	-	0.3%
Other (as described)	MINOR EQUIPMENT	$23,055	$2,650	$20,405	-	0.1%
Fees: lobbying		$5,700	-	$5,700	-	0.0%
Other (as described)	INTERCOMPANY REIMBURSEM	-$948,047	$3,977,875	-$4,925,922	-	-5.9%
Total		$15,989,123				100%

View the filing

2016 · Form 990 · $20,559,896 spent · pay $7,521,547 · grants $0 · events $81,452

Line	As described	Total	Program	Management	Fundraising	Share
Other (as described)	Intercompany Reimbursem	$6,084,018	$6,084,018	-	-	29.6%
Other salaries and wages		$5,890,317	$3,087,702	$2,802,615	-	28.6%
Other (as described)	Research Supplies	$2,115,333	$2,115,333	-	-	10.3%
Pay: officers, directors, trustees, key employees		$1,236,911	-	$1,236,911	-	6.0%
Interest		$894,284	-	$894,284	-	4.3%
Information technology		$686,752	$7,224	$679,528	-	3.3%
Insurance		$588,621	-	$588,621	-	2.9%
Depreciation and depletion		$579,647	$137,438	$442,209	-	2.8%
Fees: accounting		$546,076	-	$546,076	-	2.7%
Occupancy		$355,464	$63,726	$291,738	-	1.7%
Other (as described)	SUPPLIES	$280,445	$46,927	$233,518	-	1.4%
Office expenses		$272,646	$53,649	$218,997	-	1.3%
Payroll taxes		$270,297	$115,321	$154,976	-	1.3%
Travel		$235,478	$147,546	$87,932	-	1.1%
All other expenses		$196,656	$101,000	$95,656	-	1.0%
Other (as described)	Bad Debt Expense	$186,920	$186,920	-	-	0.9%
Pension plan contributions		$124,022	-	$124,022	-	0.6%
Conferences, conventions and meetings		$81,452	$33,730	$47,722	-	0.4%
Fees: legal		$67,085	-	$67,085	-	0.3%
Advertising and promotion		$56,969	$37,164	$19,805	-	0.3%
Fees: investment management		$35,580	-	$35,580	-	0.2%
Fees: other services		-$225,077	$4,005,399	-$4,230,476	-	-1.1%
Total		$20,559,896				100%

View the filing

2012 · Form 990 · $38,265,599 spent · pay $33,461,802 · grants $0 · events $1,739

Line	As described	Total	Program	Management	Fundraising	Share
Other salaries and wages		$22,206,919	$18,521,402	$3,685,517	-	58.0%
Other employee benefits		$8,047,976	$6,164,460	$1,883,516	-	21.0%
Pay: officers, directors, trustees, key employees		$2,125,552	$300,676	$1,824,876	-	5.6%
Fees: other services		$1,788,560	$1,394,319	$394,241	-	4.7%
Depreciation and depletion		$1,337,046	-	$1,337,046	-	3.5%
Occupancy		$952,738	-	$952,738	-	2.5%
Travel		$889,387	$504,922	$384,465	-	2.3%
Payroll taxes		$583,217	$443,624	$139,593	-	1.5%
Pension plan contributions		$498,138	$453,182	$44,956	-	1.3%
Interest		$479,732	-	$479,732	-	1.3%
Fees: management		$440,728	-	$440,728	-	1.2%
Other (as described)	BAD DEBT EXPENSE	$301,455	$0	$301,455	-	0.8%
Information technology		$299,335	$50,057	$249,278	-	0.8%
Other (as described)	RECOVERY AND ALLOCATION	$245,096	$245,096	-	-	0.6%
Insurance		$237,559	-	$237,559	-	0.6%
Other (as described)	COMPUTER & EQUIPMENT MA	$226,713	$1,782	$224,931	-	0.6%
Fees: accounting		$204,923	-	$204,923	-	0.5%
Other (as described)	BOOKS/SUBSCRIPTIONS/MEM	$178,672	$99	$178,573	-	0.5%
Office expenses		$108,622	-	$108,622	-	0.3%
Fees: legal		$101,833	-	$101,833	-	0.3%
Fees: investment management		$85,219	-	$85,219	-	0.2%
Advertising and promotion		$77,511	-	$77,511	-	0.2%
Fees: lobbying		$41,389	-	$41,389	-	0.1%
Conferences, conventions and meetings		$1,739	-	$1,739	-	0.0%
All other expenses		-$3,194,460	-	-$3,194,460	-	-8.3%
Total		$38,265,599				100%

View the filing

2011 · Form 990 · $49,699,380 spent · pay $43,423,748 · grants $0 · events $0

Line	As described	Total	Program	Management	Fundraising	Share
Other salaries and wages		$29,576,689	$26,388,189	$3,188,500	-	59.5%
Other employee benefits		$6,587,431	$5,036,826	$1,550,605	-	13.3%
Pension plan contributions		$2,871,667	$2,562,088	$309,579	-	5.8%
Payroll taxes		$2,581,545	$2,303,243	$278,302	-	5.2%
Depreciation and depletion		$2,303,466	$1,925,026	$378,440	-	4.6%
Pay: officers, directors, trustees, key employees		$1,806,416	$1,611,676	$194,740	-	3.6%
Travel		$1,174,855	$779,673	$395,182	-	2.4%
Other (as described)	CORPORATE ALLOCATION	$866,844	$773,631	$93,213	-	1.7%
Insurance		$528,074	-	$528,074	-	1.1%
Fees: management		$488,400	-	$488,400	-	1.0%
Interest		$388,121	-	$388,121	-	0.8%
Fees: accounting		$140,597	-	$140,597	-	0.3%
Advertising and promotion		$113,933	-	$113,933	-	0.2%
Fees: other services		$85,930	$53,892	$32,038	-	0.2%
Office expenses		$85,919	-	$85,919	-	0.2%
Fees: lobbying		$66,873	-	$66,873	-	0.1%
Occupancy		$32,620	-	$32,620	-	0.1%
Total		$49,699,380				100%

View the filing

2010 · Form 990 · $44,352,653 spent · pay $38,932,613 · grants $0 · events $0

Line	As described	Total	Program	Management	Fundraising	Share
Other salaries and wages		$25,626,411	$25,327,326	$299,085	-	57.8%
Other employee benefits		$5,801,794	$5,801,794	-	-	13.1%
Pension plan contributions		$2,943,098	-	$2,943,098	-	6.6%
Payroll taxes		$2,694,055	-	$2,694,055	-	6.1%
Other (as described)	CORPORATE ALLOCATION	$2,379,191	$2,353,336	$25,855	-	5.4%
Pay: officers, directors, trustees, key employees		$1,867,255	$1,724,814	$142,441	-	4.2%
Depreciation and depletion		$1,182,560	-	$1,182,560	-	2.7%
Travel		$936,152	$924,530	$11,622	-	2.1%
Fees: management		$480,000	-	$480,000	-	1.1%
Insurance		$183,013	-	$183,013	-	0.4%
Fees: other services		$179,015	-	$179,015	-	0.4%
Occupancy		$75,063	-	$75,063	-	0.2%
Fees: accounting		$4,649	-	$4,649	-	0.0%
Fees: legal		$282	-	$282	-	0.0%
Office expenses		$115	-	$115	-	0.0%
Total		$44,352,653				100%

View the filing

2009 · Form 990 · $20,455,248 spent · pay $3,369,543 · grants $0 · events $0

Line	As described	Total	Program	Management	Fundraising	Share
Other (as described)	Corporate allocation	$8,762,064	$6,571,548	$2,190,516	-	42.8%
Occupancy		$2,492,842	$1,869,632	$623,210	-	12.2%
Other (as described)	Service center expenses	$1,824,581	$1,368,436	$456,145	-	8.9%
Other salaries and wages		$1,382,082	$1,036,561	$345,521	-	6.8%
Pay: officers, directors, trustees, key employees		$1,213,549	$910,162	$303,387	-	5.9%
Other (as described)	Project/Office Supplies	$1,081,567	$811,175	$270,392	-	5.3%
Depreciation and depletion		$1,075,777	$806,833	$268,944	-	5.3%
Other (as described)	SSA goodwill amortizati	$741,678	$556,259	$185,419	-	3.6%
Pension plan contributions		$406,069	$304,552	$101,517	-	2.0%
Interest		$384,164	$288,123	$96,041	-	1.9%
Payroll taxes		$367,843	$275,882	$91,961	-	1.8%
All other expenses		$292,974	$219,730	$73,244	-	1.4%
Fees: other services		$238,474	$178,855	$59,619	-	1.2%
Other (as described)	Project Expenses	$100,309	$75,232	$25,077	-	0.5%
Travel		$91,275	$68,456	$22,819	-	0.4%
Total		$20,455,248				100%

View the filing

Federal lobbying

Lobbying Disclosure Act reports naming a client or registrant with this organization's name and state. Spent: what lobbying for it cost (firm income plus its own reported expenses). Earned: income it reported as a lobbying firm.

Year	Spent	Reports
2026	$40,000	2
2025	$80,000	4
2024	$80,000	4
2023	$80,000	4
2022	$80,000	4
2021	$80,000	4
2020	$80,000	4
2019	$20,000	4
2018	$180,000	4
2017	$200,000	4
2016	$200,000	4
2015	$110,000	4
2014	$90,000	5
2013	$100,000	6
2012	$200,000	4
2011	$150,000	5
2010	$140,000	5
2009	$150,000	5
2008	$220,000	4
2007	$260,000	3
2006	$160,000	2
2005	$20,000	2

Issues: Budget/Appropriations, Real Estate/Land Use/Conservation, Environment/Superfund, Defense, Animals, Medical/Disease Research/Clinical Labs, Veterans, Homeland Security, Energy/Nuclear

Firms hired: CASSIDY & ASSOCIATES, INC.

Federal grants and contracts

Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.

Fiscal year	Grants and other assistance	Contracts	Awards
2026	$9,436,265	$2,063,941	44
2025	$12,961,891	$18,936,044	52
2024	$8,239,600	$948,075	54
2023	$6,317,431	$10,286,370	56
2022	$8,709,912	$9,654,479	52
2021	$2,552,732	$304,100	11
2018	$0	$0	1
2014	$0	$0	1
2013	$0	$0	1
2012	$0	$74,786	1
2011	$0	$0	1
2010	$0	$75,057	1
2009	$0	$201,240	1

Largest awards · 171 shown

Year	Agency	Kind	Program	Description	Obligated
2026	Office of Assistant Secretary for Preparedness and Response	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1	$3,723,027
2026	Food and Drug Administration	Contract	OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690	NICOTINE FLUX: INVESTIGATING THE IMPACT OF ENDS OUTPUT POWER AND HEATING ELEMENT ON ABUSE LIABILITY	$3,017,553
2026	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712	NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND	$1,282,991
2026	National Institutes of Health	Grant or other assistance	EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853	THE IMPACT OF DIFFUSE MILD BRAIN INJURY ON CLINICAL OUTCOMES IN CHILDREN	$1,004,788
2026	National Institutes of Health	Grant or other assistance	CARDIOVASCULAR DISEASES RESEARCH 93.837	MECHANISM AND COUNTERMEASURE OF FENTANYL-INDUCED SUDDEN DEATH - PROJECT SUMMARY OPIOIDS WERE INVOLVED IN 75,673 OVERDOSE DEATHS IN 2020 IN THE U.S. FENTANYL, AN	$898,339
2026	National Institutes of Health	Grant or other assistance	DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279	APPLYING NEUROMODULATION TO BOOST THE EFFICACY OF MOTIVATIONAL INTERVIEWING - THE USE OF CANNABIS AND ALCOHOL IS ASSOCIATED WITH MYRIAD HEALTH CONSEQUENCES INCL	$890,994
2026	National Institutes of Health	Grant or other assistance	ALCOHOL RESEARCH PROGRAMS 93.273	THE SYNCHRONY STUDY: A RANDOMIZED CONTROLLED TRIAL OF MUSIC TRAINING FOR CHILDREN - ABSTRACT RECENT ESTIMATES INDICATE THAT, CONSERVATIVELY, UP TO 5% OF CHILDR	$853,415
2026	National Institutes of Health	Grant or other assistance	MENTAL HEALTH RESEARCH GRANTS 93.242	MULTIMODAL PREDICTION OF BEHAVIORAL AND MENTAL HEALTH OUTCOMES IN INCARCERATED WOMEN - PROJECT SUMMARY/ABSTRACT RESEARCH IN PSYCHOLOGY AND NEUROSCIENCE HAS HELP	$813,689
2026	National Institutes of Health	Grant or other assistance	DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279	NEUROCOGNITIVE ABNORMALITIES IN STIMULANT ABUSE AMONG HIGH-RISK WOMEN - PROJECT ABSTRACT THERE CONTINUES TO BE GREAT INTEREST AND PUBLIC/HEALTH/RELEVANCE WITH	$777,825
2026	National Institutes of Health	Grant or other assistance	DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279	MATCHING TREATMENTS TO COGNITIVE DEFICITS IN OFFENDERS WITH SUBSTANCE USE DISORDERS - PROJECT SUMMARY/ABSTRACT PRIOR RESEARCH HAS IDENTIFIED TWO SUBTYPES OF A	$773,364
2026	National Institutes of Health	Grant or other assistance	ALCOHOL RESEARCH PROGRAMS 93.273	MULTIMODAL IMAGING OF PRENATAL ALCOHOL EXPOSURE: MECHANISMS UNDERLYING SPATIAL NAVIGATION MEMORY DEFICITS IN CHILDREN AND ADOLESCENTS - PROJECT SUMMARY/ABSTRACT	$737,461
2026	National Institutes of Health	Grant or other assistance	EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853	COGNITIVE SEQUELAE OF CEREBROVASCULAR AND GUT DYSFUNCTION IN POST-ACUTE COVID-19 SYNDROME. - ABSTRACT: APPROXIMATELY ONE THIRD OF NON-HOSPITALIZED CORONAVIRUS D	$715,659
2026	National Institutes of Health	Grant or other assistance	EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853	BIOLOGICAL MECHANISMS UNDERLYING PROGRESSIVE DECLINE FOLLOWING GERIATRIC TRAUMATIC BRAIN INJURY - ABSTRACT: GERIATRIC “MILD” TRAUMATIC BRAIN INJURY (GTBI) IS A	$690,732
2026	National Institutes of Health	Grant or other assistance	ALCOHOL RESEARCH PROGRAMS 93.273	ATTENDING TO ALL CHILDREN: EXAMINING THE ROLE OF ALPHA OSCILLATIONS IN ATTENTION IN YOUNG CHILDREN WITH AND WITHOUT PRENATAL ALCOHOL EXPOSURE (ASCEND) - ABSTRAC	$648,391
2026	National Institutes of Health	Grant or other assistance	EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853	A LONGITUDINAL STUDY OF TRAUMATIC BRAIN INJURY IN A HIGH-RISK POPULATION - PROJECT SUMMARY/ABSTRACT TRAUMATIC BRAIN INJURY (TBI) IS A GLOBAL CONCERN THAT PRECIP	$634,244
2026	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN	$350,840
2026	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	GLP REPEAT DOSE TOXICOLOGY STUDY FOR A LIVE-ATTENUATED RESPIRATORY VIRUS VACCINE.	$339,533
2026	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	EFFICACY AND SAFETY EVALUATION OF LEAD GENE THERAPY CANDIDATE IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT	$303,277
2026	Office of Assistant Secretary for Preparedness and Response	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON	$148,448
2026	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN METHYL MELANOMIC ACIDEMIA (MMAB) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOP	$86,007
2026	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	THE CONTRACTOR SHALL PERFORM THE TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGESTREL IN RAT AND NON	$54,811
2026	Defense Health Agency	Contract	SOFTWARE PUBLISHERS 511210	LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR.	$43,608
2026	Office of Assistant Secretary for Preparedness and Response	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES	$21,588
2026	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS	-$2,000
2026	National Institutes of Health	Grant or other assistance	AGING RESEARCH 93.866	CEREBROVASCULAR CONTRIBUTIONS TO COGNITIVE IMPAIRMENT IN LEWY BODY DEMENTIAS - PROJECT SUMMARY / ABSTRACT COGNITIVE DECLINE IN LEWY BODY DEMENTIAS [PARKINSON’S	-$2,635
2026	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY - TASK AREA A: CORE ADMINISTRATIVE ACTIVITIES	-$7,213
2026	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY	-$62,736
2026	Food and Drug Administration	Contract	TESTING LABORATORIES AND SERVICES 541380	STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.	-$7,235,794
2025	Food and Drug Administration	Contract	TESTING LABORATORIES AND SERVICES 541380	STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.	$9,762,422
2025	Food and Drug Administration	Contract	TESTING LABORATORIES AND SERVICES 541380	SOLE SOURCE AWARD OF A 24-MONTH PERIOD, FIRM FIXED PRICE (FFP), ENDS TOXICOLOGICAL STUDIES FOR CENTER FOR TOBACCO PRODUCTS (CTP).	$7,058,881
2025	National Science Foundation	Grant or other assistance	INTEGRATIVE ACTIVITIES 47.083	EQUIPMENT: MRI: TRACK 2 MEG SYSTEM WITH INTEGRATED HELIUM RECOVERY EQUIPMENT FOR COGNITIVE NEUROSCIENCE -THE MAJOR RESEARCH INSTRUMENTATION PROJECT SUPPORTS THE	$2,612,688
2025	Office of Assistant Secretary for Preparedness and Response	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON	$2,039,302
2025	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712	NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND	$1,745,514
2025	National Institutes of Health	Grant or other assistance	CARDIOVASCULAR DISEASES RESEARCH 93.837	MECHANISM AND COUNTERMEASURE OF FENTANYL-INDUCED SUDDEN DEATH - PROJECT SUMMARY OPIOIDS WERE INVOLVED IN 75,673 OVERDOSE DEATHS IN 2020 IN THE U.S. FENTANYL, AN	$944,202
2025	National Institutes of Health	Grant or other assistance	MENTAL HEALTH RESEARCH GRANTS 93.242	MULTIMODAL PREDICTION OF BEHAVIORAL AND MENTAL HEALTH OUTCOMES IN INCARCERATED WOMEN - PROJECT SUMMARY/ABSTRACT RESEARCH IN PSYCHOLOGY AND NEUROSCIENCE HAS HELP	$904,100
2025	National Institutes of Health	Grant or other assistance	DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279	APPLYING NEUROMODULATION TO BOOST THE EFFICACY OF MOTIVATIONAL INTERVIEWING - THE USE OF CANNABIS AND ALCOHOL IS ASSOCIATED WITH MYRIAD HEALTH CONSEQUENCES INCL	$899,869
2025	National Institutes of Health	Grant or other assistance	EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853	MICROBIOME-GUT-BRAIN DYSFUNCTION IN PRODROMAL AND SYMPTOMATIC LEWY BODY DISEASES - PROJECT SUMMARY/ABSTRACT COGNITIVE DECLINE IN LEWY BODY DEMENTIAS [PARKINSON	$889,363
2025	National Institutes of Health	Grant or other assistance	ALCOHOL RESEARCH PROGRAMS 93.273	THE SYNCHRONY STUDY: A RANDOMIZED CONTROLLED TRIAL OF MUSIC TRAINING FOR CHILDREN - ABSTRACT RECENT ESTIMATES INDICATE THAT, CONSERVATIVELY, UP TO 5% OF CHILDR	$852,356
2025	National Institutes of Health	Grant or other assistance	EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853	THE IMPACT OF DIFFUSE MILD BRAIN INJURY ON CLINICAL OUTCOMES IN CHILDREN	$821,974
2025	National Institutes of Health	Grant or other assistance	DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279	NEUROCOGNITIVE ABNORMALITIES IN STIMULANT ABUSE AMONG HIGH-RISK WOMEN - PROJECT ABSTRACT THERE CONTINUES TO BE GREAT INTEREST AND PUBLIC/HEALTH/RELEVANCE WITH	$794,633
2025	National Institutes of Health	Grant or other assistance	DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279	MATCHING TREATMENTS TO COGNITIVE DEFICITS IN OFFENDERS WITH SUBSTANCE USE DISORDERS - PROJECT SUMMARY/ABSTRACT PRIOR RESEARCH HAS IDENTIFIED TWO SUBTYPES OF A	$788,790
2025	National Institutes of Health	Grant or other assistance	ALCOHOL RESEARCH PROGRAMS 93.273	MULTIMODAL IMAGING OF PRENATAL ALCOHOL EXPOSURE: MECHANISMS UNDERLYING SPATIAL NAVIGATION MEMORY DEFICITS IN CHILDREN AND ADOLESCENTS - PROJECT SUMMARY/ABSTRACT	$733,704
2025	National Institutes of Health	Grant or other assistance	EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853	COGNITIVE SEQUELAE OF CEREBROVASCULAR AND GUT DYSFUNCTION IN POST-ACUTE COVID-19 SYNDROME. - ABSTRACT: APPROXIMATELY ONE THIRD OF NON-HOSPITALIZED CORONAVIRUS D	$724,725
2025	National Institutes of Health	Grant or other assistance	ALCOHOL RESEARCH PROGRAMS 93.273	ATTENDING TO ALL CHILDREN: EXAMINING THE ROLE OF ALPHA OSCILLATIONS IN ATTENTION IN YOUNG CHILDREN WITH AND WITHOUT PRENATAL ALCOHOL EXPOSURE (ASCEND) - ABSTRAC	$713,764
2025	National Institutes of Health	Grant or other assistance	EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853	A LONGITUDINAL STUDY OF TRAUMATIC BRAIN INJURY IN A HIGH-RISK POPULATION - PROJECT SUMMARY/ABSTRACT TRAUMATIC BRAIN INJURY (TBI) IS A GLOBAL CONCERN THAT PRECIP	$670,150
2025	National Institutes of Health	Grant or other assistance	TRANS-NIH RESEARCH SUPPORT 93.310	MECHANISM AND COUNTERMEASURE OF CARFENTANIL-INDUCED RESPIRATORY DISORDER AND DEATH - PROJECT SUMMARY OPIOIDS WERE INVOLVED IN 75,673 OVERDOSE DEATHS IN 2020 IN	$651,000
2025	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	THE CONTRACTOR SHALL PERFORM THE TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGESTREL IN RAT AND NON	$139,107
2025	Defense Health Agency	Contract	SOFTWARE PUBLISHERS 511210	LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR.	$42,338
2025	Office of Assistant Secretary for Preparedness and Response	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES	$21,195
2025	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES.	$10,000
2025	National Institutes of Health	Grant or other assistance	FAMILY SMOKING PREVENTION AND TOBACCO CONTROL ACT REGULATORY RESEARCH 93.077	ASSESSING TOXICANT PROPERTIES AND HEALTH EFFECTS OF CIGARILLO AND HOOKAH TOBACCO AEROSOLS IN RATS	$0
2025	National Institutes of Health	Grant or other assistance	ALCOHOL RESEARCH PROGRAMS 93.273	MINDFULNESS FOR ALCOHOL ABUSING OFFENDERS: MECHANISMS AND OUTCOMES	-$66
2025	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY/TOXICOLOGY CORE LABORATORY - SCIENTIFIC PROJECT FOR RSA NO. 2057 (RADER)	-$28,988
2025	National Institutes of Health	Grant or other assistance	CANCER CAUSE AND PREVENTION RESEARCH 93.393	DNA REPAIR CAPACITY ASSAYS FOR LUNG DISEASE RISK ASSESSMENT	-$39,360
2025	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712	TRANSFER AND VALIDATION OF BIOANALYTICAL METHOD FOR DETECTION OF CABOTEGRAVIR IN RAT PLASMA	-$55,504
2025	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	CHARACTERIZATION OF A DOWNSTREAM GENE THERAPEUTIC FOR THE REPARATIVE TREATMENT OF SEVERE FRACTURES PERIOD OF PERFORMANCE SEPTEMBER 24, 2020 - NOVEMBER 23, 2021	-$79,486
2025	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY	-$110,620
2025	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	TASK ORDER ENTITLED, "PHARMACODYNAMICS OF THE MAS-RELATED GENE X2 (MRGX2) ANTAGONIST SYR268215 IN THE HUMANIZED MRGX2 KNOCK-IN (KI) MOUSE."	-$174,820
2025	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN METHYL MELANOMIC ACIDEMIA (MMAB) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOP	-$256,960
2025	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	GTRP: PHARMACOLOGY/TOXICOLOGY CORE LABORATORY PROJECT FOR RSA NO. 2034	-$480,276
2025	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	THE NHLBI REQUIRES THE GENE THERAPY RESOURCE PROGRAM (GTRP) SUPPORT TRANSLATIONAL GENE THERAPY RESEARCH BY PROVIDING RESOURCES AND SERVICES FROM THREE CORE LABO	-$696,057
2024	Office of Assistant Secretary for Preparedness and Response	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON	$1,730,877
2024	Defense Health Agency	Grant or other assistance	MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420	A NOVEL ADVANCED RESUSCITATION FLUID FOR A SWINE POLYTRAUMA MODEL (TRAUMATIC BRAIN INJURY AND HEMORRHAGIC SHOCK)	$1,086,750
2024	National Institutes of Health	Grant or other assistance	EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853	MICROBIOME-GUT-BRAIN DYSFUNCTION IN PRODROMAL AND SYMPTOMATIC LEWY BODY DISEASES - PROJECT SUMMARY/ABSTRACT COGNITIVE DECLINE IN LEWY BODY DEMENTIAS [PARKINSON	$932,250
2024	National Institutes of Health	Grant or other assistance	CARDIOVASCULAR DISEASES RESEARCH 93.837	MECHANISM AND COUNTERMEASURE OF FENTANYL-INDUCED SUDDEN DEATH - PROJECT SUMMARY OPIOIDS WERE INVOLVED IN 75,673 OVERDOSE DEATHS IN 2020 IN THE U.S. FENTANYL, AN	$897,591
2024	National Institutes of Health	Grant or other assistance	ALCOHOL RESEARCH PROGRAMS 93.273	ATTENDING TO ALL CHILDREN: EXAMINING THE ROLE OF ALPHA OSCILLATIONS IN ATTENTION IN YOUNG CHILDREN WITH AND WITHOUT PRENATAL ALCOHOL EXPOSURE (ASCEND) - ABSTRAC	$877,406
2024	National Institutes of Health	Grant or other assistance	TRANS-NIH RESEARCH SUPPORT 93.310	A LONGITUDINAL STUDY OF TRAUMATIC BRAIN INJURY IN A HIGH-RISK POPULATION - PROJECT SUMMARY/ABSTRACT TRAUMATIC BRAIN INJURY (TBI) IS A GLOBAL CONCERN THAT PRECIP	$830,832
2024	National Institutes of Health	Grant or other assistance	DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279	MATCHING TREATMENTS TO COGNITIVE DEFICITS IN OFFENDERS WITH SUBSTANCE USE DISORDERS - PROJECT SUMMARY/ABSTRACT PRIOR RESEARCH HAS IDENTIFIED TWO SUBTYPES OF A	$812,460
2024	National Institutes of Health	Grant or other assistance	DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279	NEUROCOGNITIVE ABNORMALITIES IN STIMULANT ABUSE AMONG HIGH-RISK WOMEN - PROJECT ABSTRACT THERE CONTINUES TO BE GREAT INTEREST AND PUBLIC/HEALTH/RELEVANCE WITH	$802,751
2024	National Institutes of Health	Grant or other assistance	EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853	COGNITIVE SEQUELAE OF CEREBROVASCULAR AND GUT DYSFUNCTION IN POST-ACUTE COVID-19 SYNDROME. - ABSTRACT: APPROXIMATELY ONE THIRD OF NON-HOSPITALIZED CORONAVIRUS D	$709,373
2024	National Institutes of Health	Grant or other assistance	TRANS-NIH RESEARCH SUPPORT 93.310	MECHANISM AND COUNTERMEASURE OF CARFENTANIL-INDUCED RESPIRATORY DISORDER AND DEATH - PROJECT SUMMARY OPIOIDS WERE INVOLVED IN 75,673 OVERDOSE DEATHS IN 2020 IN	$651,000
2024	National Institutes of Health	Grant or other assistance	AGING RESEARCH 93.866	THE MECHANISMS OF CEREBRAL MICROCIRCULATION RESPONSE TO TRANSCRANIAL STIMULATION. - TRANSCRANIAL ALTERNATING CURRENT STIMULATION (TACS) IS A RELATIVELY NEW NON-	$596,750
2024	National Institutes of Health	Grant or other assistance	ALCOHOL RESEARCH PROGRAMS 93.273	THE SYNCHRONY STUDY: A RANDOMIZED CONTROLLED TRIAL OF MUSIC TRAINING FOR CHILDREN WITH FASD - ABSTRACT RECENT ESTIMATES INDICATE THAT, CONSERVATIVELY, UP TO 5%	$307,308
2024	Defense Health Agency	Contract	SOFTWARE PUBLISHERS 511210	LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR.	$225,129
2024	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	RESPIRATORY INTERACTION STUDIES IN RODENTS, ABILITY OF A TEST ARTICLE TO REVERSE THE RESPIRATORY DEPRESSANT EFFECTS OF OPIOIDS. TO5. PERIOD OF PERFORMANCE: MARC	$211,128
2024	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	CHARACTERIZATION OF SPONTANEOUS OSTEOGENESIS AFTER SURGICAL SEGMENTAL BONE DEFECT IN A LARGE ANIMAL	$192,050
2024	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	EVALUATION OF POTENTIAL RESPIRATORY STIMULANT. TO4. PERIOD OF PERFORMANCE: MARCH 21, 2024 - MARCH 20, 2025.	$140,848
2024	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	CHARACTERIZATION OF A DOWNSTREAM GENE THERAPEUTIC FOR THE REPARATIVE TREATMENT OF SEVERE FRACTURES PERIOD OF PERFORMANCE SEPTEMBER 24, 2020 - NOVEMBER 23, 2021	$133,039
2024	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2	$120,890
2024	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN PROPIONIC ACIDEMIA (PA) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT. PER	$51,059
2024	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	BIOANALYTICAL SUPPORTS FOR A GLP TOX/BIODISTRIBUTION STUDY IN MINI-PIGS	$44,201
2024	Office of Assistant Secretary for Preparedness and Response	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES	$37,058
2024	National Institutes of Health	Contract	TESTING LABORATORIES AND SERVICES 541380	24-015894 NHLBI POPULATION SCIENCES BRANCH REQUIRES PULMONARY FUNCTION TESTING TO DETERMINE IF THE FLEXIVENT METHOD OF PULMONARY FUNCTION TESTING IS SUITABLE TO	$16,653
2024	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY - TASK AREA A: CORE ADMINISTRATIVE ACTIVITIES	$10,766
2024	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	KICK-OFF MEETING FOR THE PHARMACOLOGY STUDIES AND ANIMAL MODEL DEVELOPMENT AND RELATED SERVICES FOR DRUG DEVELOPMENT IDIQ CONTRACT.	$1,000
2024	Department of the Army	Contract	SOFTWARE PUBLISHERS 511210	IGF::OT::IGF ANIMAL MANAGEMENT SYSTEM SOFTWARE LICENSE/SUPPORT	$0
2024	National Institutes of Health	Grant or other assistance	EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853	BRAIN INJURY TREATMENT BY MODULATION OF HEMODYNAMICS WITH BLOOD SOLUBLE DRAG REDUCING MOLECULES	-$16,479
2024	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	THE NHLBI REQUIRES THE GENE THERAPY RESOURCE PROGRAM (GTRP) SUPPORT TRANSLATIONAL GENE THERAPY RESEARCH BY PROVIDING RESOURCES AND SERVICES FROM THREE CORE LABO	-$29,071
2024	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712	TRANSFER AND VALIDATION OF BIOANALYTICAL METHOD FOR DETECTION OF CABOTEGRAVIR IN RAT PLASMA	-$38,207
2024	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	EVALUATION OF DRUG EFFICACY IN A RAT MODEL OF NEUROPATHIC PAIN	-$63,192
2024	National Institutes of Health	Grant or other assistance	CANCER TREATMENT RESEARCH 93.395	INHALED DELIVERY OF VIDAZA FOR TARGETED EPIGENETIC LUNG CANCER THERAPY	-$116,357
2024	National Institutes of Health	Grant or other assistance	DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279	NEURAL CIRCUIT CONTROL OF MESOLIMBIC DOPAMINE AND REWARD	-$132,033
2024	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	EVALUATION OF DRUG EFFICACY IN A GUINEA PIG MODEL OF NEONATAL OPIOID WITHDRAWAL SYNDROME	-$150,985
2024	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712	LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE: TO PERFORM NON-CLINICAL SAFETY ASSESSMENT OF TTHX1114 TO SUPPORT FUCHS ENDOTHELIAL CORNEAL DYSTROPHY I	-$156,237
2024	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	DISEASE MODEL CHARACTERIZATION AND DEVELOPMENT OF ASSAYS TO EVALUATE AND MEASURE PAIN IN A PORCINE MODEL FOR SICKLE CELL DISEASE (SCD)	-$165,600
2024	Office of Assistant Secretary for Preparedness and Response	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY 541711	PROJECT RTOR BIO-AMT-1021: DEVELOPMENT OF ANIMAL MODELS FOR EVALUATION OF MEDICAL COUNTERMEASURES FOR SARS-COV-2	-$1,363,328
2023	Food and Drug Administration	Contract	OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690	TASK ORDER 1 -TITLE: ARE REDUCTIONS IN BOE, BOPH, AND OTHER HEALTH RISK MARKERS PROPORTIONAL TO REDUCTIONS IN CIGARETTE SMOKING UPON SWITCHING TO ENDS	$3,872,713
2023	Office of Assistant Secretary for Preparedness and Response	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON	$1,986,391
2023	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	EFFICACY AND SAFETY EVALUATION OF LEAD GENE THERAPY CANDIDATE IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT	$1,595,870
2023	Food and Drug Administration	Contract	OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690	TASK ORDER 2 - EXAMINING THE INFLUENCE OF SYNTHETIC COOLING AGENTS ON CIGARETTE SENSORY AND SUBJECTIVE EFFECTS AND USE BEHAVIOR	$1,251,731
2023	National Institutes of Health	Grant or other assistance	TRANS-NIH RESEARCH SUPPORT 93.310	A LONGITUDINAL STUDY OF TRAUMATIC BRAIN INJURY IN A HIGH-RISK POPULATION - PROJECT SUMMARY/ABSTRACT TRAUMATIC BRAIN INJURY (TBI) IS A GLOBAL CONCERN THAT PRECIP	$959,797
2023	National Institutes of Health	Grant or other assistance	CARDIOVASCULAR DISEASES RESEARCH 93.837	MECHANISM AND COUNTERMEASURE OF FENTANYL-INDUCED SUDDEN DEATH - PROJECT SUMMARY OPIOIDS WERE INVOLVED IN 75,673 OVERDOSE DEATHS IN 2020 IN THE U.S. FENTANYL, AN	$940,773
2023	National Institutes of Health	Grant or other assistance	AGING RESEARCH 93.866	MICROBIOME-GUT-BRAIN DYSFUNCTION IN PRODROMAL AND SYMPTOMATIC LEWY BODY DISEASES - PROJECT SUMMARY/ABSTRACT COGNITIVE DECLINE IN LEWY BODY DEMENTIAS [PARKINSON	$815,866
2023	National Institutes of Health	Grant or other assistance	DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279	NEUROCOGNITIVE ABNORMALITIES IN STIMULANT ABUSE AMONG HIGH-RISK WOMEN - PROJECT ABSTRACT THERE CONTINUES TO BE GREAT INTEREST AND PUBLIC/HEALTH/RELEVANCE WITH	$808,853
2023	National Institutes of Health	Grant or other assistance	EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853	COGNITIVE SEQUELAE OF CEREBROVASCULAR AND GUT DYSFUNCTION IN POST-ACUTE COVID-19 SYNDROME. - ABSTRACT: APPROXIMATELY ONE THIRD OF NON-HOSPITALIZED CORONAVIRUS D	$737,345
2023	National Institutes of Health	Grant or other assistance	BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859	ATTENDING TO ALL CHILDREN: EXAMINING THE ROLE OF ALPHA OSCILLATIONS IN ATTENTION IN YOUNG CHILDREN WITH AND WITHOUT PRENATAL ALCOHOL EXPOSURE (ASCEND) - ABSTRAC	$734,167
2023	National Institutes of Health	Grant or other assistance	TRANS-NIH RESEARCH SUPPORT 93.310	MECHANISM AND COUNTERMEASURE OF CARFENTANIL-INDUCED RESPIRATORY DISORDER AND DEATH - PROJECT SUMMARY OPIOIDS WERE INVOLVED IN 75,673 OVERDOSE DEATHS IN 2020 IN	$651,000
2023	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN PROPIONIC ACIDEMIA (PA) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT. PER	$379,767
2023	National Institutes of Health	Grant or other assistance	ALCOHOL RESEARCH PROGRAMS 93.273	THE SYNCHRONY STUDY: A RANDOMIZED CONTROLLED TRIAL OF MUSIC TRAINING FOR CHILDREN WITH FASD - ABSTRACT RECENT ESTIMATES INDICATE THAT, CONSERVATIVELY, UP TO 5%	$311,724
2023	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY	$234,478
2023	Defense Health Agency	Grant or other assistance	MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420	EFFECTS OF ALTITUDE DURING ROTARY WING TRANSPORT IN A LARGE-ANIMAL POLYTRAUMA MODEL	$222,662
2023	Department of the Army	Contract	SOFTWARE PUBLISHERS 511210	LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR.	$218,571
2023	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	CHARACTERIZATION OF SPONTANEOUS OSTEOGENESIS AFTER SURGICAL SEGMENTAL BONE DEFECT IN A LARGE ANIMAL	$193,654
2023	National Institutes of Health	Grant or other assistance	AGING RESEARCH 93.866	CEREBROVASCULAR CONTRIBUTIONS TO COGNITIVE IMPAIRMENT IN LEWY BODY DEMENTIAS - PROJECT SUMMARY / ABSTRACT COGNITIVE DECLINE IN LEWY BODY DEMENTIAS [PARKINSON’S	$181,000
2023	National Institutes of Health	Contract	TESTING LABORATORIES AND SERVICES 541380	EVALUATION OF AN ASO IN THE MOUSE CIGARETTE SMOKE AND INFLUENZA MODEL	$171,374
2023	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2	$168,560
2023	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN	$127,947
2023	Food and Drug Administration	Contract	OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690	CTP-2022-111127 - SALTS	$53,449
2023	Department of the Air Force	Contract	TESTING LABORATORIES AND SERVICES 541380	COVID-19 THE PURPOSE OF VIDER IS TO UNDERSTAND THE EFFECTIVENESS OF RF DIRECTED ENERGY RADIATION IN REDUCING THE VIABILITY OF VIRAL AEROSOLS WITH THE GOAL OF RA	$23,000
2023	Office of Assistant Secretary for Preparedness and Response	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES	$20,442
2023	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	GUARANTEED MINIMUM	$20,168
2023	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	NATURAL HISTORY STUDIES IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS. PERIOD OF PERFORMANCE SEPTEMBER 28, 2020 - DECEMBER 31, 2021	$16,749
2023	Food and Drug Administration	Contract	OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690	AWARD OF FIVE-YEAR IDIQ FOR CTP- ASSESSING TOBACCO-RELATED CLINICAL OUTCOMES AND HUMAN BEHAVIORS IN TOBACCO	$5,000
2023	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	THE PURPOSE OF THIS TASK ORDER IS THE DEVELOPMENT AND DELIVERY OF A QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) PLAN AND PARTICIPATION IN THE TASK ORDER INITIATIO	-$496
2023	Food and Drug Administration	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712	IGF::OT::IGF, IN VIVO TOXICOLOGY OF TOBACCO AND RELATED PRODUCTS	-$1,000
2023	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	THE NHLBI REQUIRES THE GENE THERAPY RESOURCE PROGRAM (GTRP) SUPPORT TRANSLATIONAL GENE THERAPY RESEARCH BY PROVIDING RESOURCES AND SERVICES FROM THREE CORE LABO	-$7,182
2023	Food and Drug Administration	Contract	RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIES 541720	IGF::OT::IGF: INVESTIGATE SUBJECTIVE EFFECTS AND NICOTINE PHARMACOKINETICS OF MENTHOLATED SMOKELESS TOBACCO PRODUCTS IN CURRENT USERS	-$8,711
2023	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	GENE THERAPY RESEARCH PROGRAM (GTRP) - PHARMACOLOGY/TOXICOLOGY CORE LABORATORY: TASK AREA D - RSA NO. 2041	-$36,102
2023	National Institutes of Health	Grant or other assistance	EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853	BRAIN INJURY TREATMENT BY MODULATION OF HEMODYNAMICS WITH BLOOD SOLUBLE DRAG REDUCING MOLECULES	-$45,755
2022	Food and Drug Administration	Contract	OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690	CTP-2022-111127 - SALTS	$2,076,573
2022	Department of the Army	Grant or other assistance	MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420	A PROSPECTIVE OBSERVATIONAL STUDY ON THERAPEUTIC AND ADVERSE EFFECTS OF MEDICAL CANNABIS FOR CHRONIC TRAUMATIC BRAIN INJURY	$1,499,922
2022	National Institutes of Health	Grant or other assistance	BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859	PHASE III COBRE: MULTIMODAL IMAGING OF NEUROPSYCHIATRIC DISORDERS (MIND)	$1,329,407
2022	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY	$1,254,413
2022	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2	$1,168,048
2022	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	DISEASE MODEL CHARACTERIZATION AND DEVELOPMENT OF ASSAYS TO EVALUATE AND MEASURE PAIN IN A PORCINE MODEL FOR SICKLE CELL DISEASE (SCD)	$1,158,007
2022	National Institutes of Health	Grant or other assistance	CANCER CAUSE AND PREVENTION RESEARCH 93.393	DNA REPAIR CAPACITY ASSAYS FOR LUNG DISEASE RISK ASSESSMENT	$806,066
2022	National Institutes of Health	Grant or other assistance	DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279	NEUROCOGNITIVE ABNORMALITIES IN STIMULANT ABUSE AMONG HIGH-RISK WOMEN - PROJECT ABSTRACT THERE CONTINUES TO BE GREAT INTEREST AND PUBLIC/HEALTH/RELEVANCE WITH	$800,808
2022	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	BIOANALYTICAL SUPPORTS FOR A GLP TOX/BIODISTRIBUTION STUDY IN MINI-PIGS	$747,851
2022	Department of the Army	Grant or other assistance	MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420	QUANTIFYING THE SENSITIVITY AND SPECIFICITY OF POINT-OF-CARE BIOMARKERS IN A LARGE-ANIMAL MODEL OF MILD TRAUMATIC BRAIN INJURY	$734,613
2022	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	GLP REPEAT DOSE TOXICOLOGY STUDY FOR BPL-24910	$716,374
2022	National Institutes of Health	Grant or other assistance	ALCOHOL RESEARCH PROGRAMS 93.273	MINDFULNESS FOR ALCOHOL ABUSING OFFENDERS: MECHANISMS AND OUTCOMES	$690,142
2022	National Institutes of Health	Grant or other assistance	EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853	A LONGITUDINAL STUDY OF TRAUMATIC BRAIN INJURY IN A HIGH-RISK POPULATION - PROJECT SUMMARY/ABSTRACT TRAUMATIC BRAIN INJURY (TBI) IS A GLOBAL CONCERN THAT PRECIP	$689,950
2022	National Institutes of Health	Grant or other assistance	BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859	ATTENDING TO ALL CHILDREN: EXAMINING THE ROLE OF ALPHA OSCILLATIONS IN ATTENTION IN YOUNG CHILDREN WITH AND WITHOUT PRENATAL ALCOHOL EXPOSURE (ASCEND) - ABSTRAC	$661,612
2022	Department of the Army	Grant or other assistance	MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420	EFFECTS OF ALTITUDE DURING ROTARY WING TRANSPORT IN A LARGE-ANIMAL POLYTRAUMA MODEL	$628,113
2022	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN	$571,054
2022	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	THE CONTRACTOR SHALL PERFORM THE TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGESTREL IN RAT AND NON	$486,301
2022	National Institutes of Health	Grant or other assistance	EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853	BRAIN INJURY TREATMENT BY MODULATION OF HEMODYNAMICS WITH BLOOD SOLUBLE DRAG REDUCING MOLECULES	$442,538
2022	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	NATURAL HISTORY STUDIES IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS. PERIOD OF PERFORMANCE SEPTEMBER 28, 2020 - DECEMBER 31, 2021	$439,560
2022	National Institutes of Health	Grant or other assistance	DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279	NEURAL CIRCUIT CONTROL OF MESOLIMBIC DOPAMINE AND REWARD	$245,741
2022	Department of the Army	Contract	SOFTWARE PUBLISHERS 511210	LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR.	$212,205
2022	National Institutes of Health	Grant or other assistance	AGING RESEARCH 93.866	CEREBROVASCULAR CONTRIBUTIONS TO COGNITIVE IMPAIRMENT IN LEWY BODY DEMENTIAS - PROJECT SUMMARY / ABSTRACT COGNITIVE DECLINE IN LEWY BODY DEMENTIAS [PARKINSON’S	$181,000
2022	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN PROPIONIC ACIDEMIA (PA) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT. PER	$172,216
2022	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. POP: SEPTEMBER 26, 2022 - MARCH 25, 2023. TASK ORDER 75N95022F	$162,965
2022	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. POP: SEPTEMBER 26, 2022 - MARCH 25, 2023. TASK ORDER 75N95022F	$148,800
2022	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. POP: SEPTEMBER 26, 2022 - SEPTEMBER 25, 2023. TASK ORDER 75N95	$102,721
2022	Office of Assistant Secretary for Preparedness and Response	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	LOVELACE BIOMEDICAL RESEARCH INSTITUTE(CHEM) - IDIQ FOR BARDA CRN ANIMAL MODEL DEVELOPMENT	$75,000
2022	Office of Assistant Secretary for Preparedness and Response	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	LOVELACE BIOMEDICAL RESEARCH INSTITUTE - BASE (BIO) - IDIQ FOR BARDA BIOLOGICAL ANIMAL MODEL AND MCM DEVELOPMENT	$75,000
2022	Office of Assistant Secretary for Preparedness and Response	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	LOVELACE BIOMEDICAL RESEARCH INSTITUTE (RADNUC) - IDIQ FOR BARDA CRN ANIMAL MODEL DEVELOPMENT	$75,000
2022	National Institutes of Health	Contract	TEMPORARY HELP SERVICES 561320	NIH/NHBLI/PSB LAB RESEARCHER REQUIRES MOUSE STUDY OF SMOKING REQUIRED IN ORDER TO TO FOLLOW UP ON RESEARCH AIMS OF LEVY LAB AND CONTINUE DEVELOPING THERAPEUTIC	$24,990
2022	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	CRO SUPPORT FOR NCATS MEDICINAL CHEMISTRY FOR LEAD OPTIMIZATION.	$4,000
2022	Defense Health Agency	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	MILITARY MEDICAL RESEARCH AND DEVELOPMENT SERVICES	$2,500
2022	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715	CONTRACT KICKOFF CONFERENCE CALL FOR CRO SUPPORT FOR NCATS MEDICINAL CHEMISTRY FOR LEAD OPTIMIZATION.	-$4,000
2022	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712	IGF::OT::IGF DEVELOP A QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) PLAN FOR ACTIVITIES CONDUCTED UNDER TASK AREA C.	-$15,098
2021	National Institutes of Health	Grant or other assistance	AGING RESEARCH 93.866	PHASE III COBRE: MULTIMODAL IMAGING OF NEUROPSYCHIATRIC DISORDERS (MIND)	$1,720,674
2021	National Institutes of Health	Grant or other assistance	CANCER CAUSE AND PREVENTION RESEARCH 93.393	DNA REPAIR CAPACITY ASSAYS FOR LUNG DISEASE RISK ASSESSMENT	$832,058
2021	Department of the Army	Contract	SOFTWARE PUBLISHERS 511210	IGF::OT::IGF ANIMAL MANAGEMENT SYSTEM SOFTWARE LICENSE/SUPPORT	$202,100
2021	Department of the Air Force	Contract	TESTING LABORATORIES 541380	COVID-19 THE PURPOSE OF VIDER IS TO UNDERSTAND THE EFFECTIVENESS OF RF DIRECTED ENERGY RADIATION IN REDUCING THE VIABILITY OF VIRAL AEROSOLS WITH THE GOAL OF RA	$100,000
2021	National Institutes of Health	Contract	RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) 541714	COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS	$2,000
2012	Centers for Disease Control and Prevention	Contract	OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690	IGF::OT::IGF OTHER FUNCTIONS - INVESTIGATE CARBON NANOMATERIAL DEPOSITION AND DEVELOP PROTOCOL	$74,786
2010	Centers for Disease Control and Prevention	Contract	OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690	TAS::75 0943::TAS CARBON NANOTUBES IN HUMAN RESPIRATORY TRACT	$75,057
2009	Office of Procurement Operations	Contract	RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) 541712	REPORT	$201,240

Patents

1 US patent filed in the last 20 years.

Lovelace Biomedical Research Institute 1 patents, 2022-03-08 to 2022-03-08 EXACT high confidence: identical full name and state

Patent	Title	Granted	Source
US 11266599	Inhalable dry powder cytidine analogue composition and method of use as a treatment for cancer	2022-03-08	PVGPATDIS, file of 2026-04-10

The newest patents of the PatentsView assignees above, matched to this record by name (and state).

LOVELACE BIOMEDICAL RESEARCH INSTITUTE

Mission

People paid by the organization

Officers and directors, no compensation reported

People by year

Highest-paid independent contractors

Who gave

Finances

Connected to

Funders of this organization

Nearby + Similar BETA

Same category: NTEE code and revenue

Who funds organizations like this

Where the money went

Federal lobbying

Federal grants and contracts

Patents

Comments